PRN News Briefs

Promotions

• Leigh Anne Gravatt: Vice Chair of Education and Associate Professor for the Department of Pharmacotherapy and Outcomes Sciences, Virginia Commonwealth University School of Pharmacy.
• Erin Hennessey: Associate Professor, St. Louis College of Pharmacy.
• Angela Miller: Team Lead Internal Medicine Pharmacy, University of Kansas Health System.
• Kurt Wargo: Interim Dean of the Wingate University School of Pharmacy.

Awards

• Kathleen Adams: Received the Brown University Department of Internal Medicine Teaching Award from the Brown University internal medicine residency program while at Rhode Island Hospital in Providence, Rhode Island.
• Nicole Asal: 2019 Rhode Island Pharmacists Association Presidential Leadership Award, University of Rhode Island College of Pharmacy.
• Brandon Collins: Preceptor Merit Award – STLCOP.
• Katherine L. March: Methodist Performing Excellence Award – Given biannually to select teams who have shown dedication to service, quality, innovation, teamwork, and integrity. Methodist University Hospital, Memphis, Tennessee.
• Julie A. Murphy: 2019 Outstanding Teacher of the Year, University of Toledo College of Pharmacy and Pharmaceutical Sciences; 2019 Donald S. Parks Advisor of the Year, University of Toledo.
• Ifeanyi Onor: Lawrence Ferring Faculty Award (Best Faculty) Xavier University of Louisiana (XULA) College of Pharmacy.
• Mate M. Soric: Class of 2019 Most Influential Professor, Northeast Ohio Medical University and Ohio Society of Health-System Pharmacists Pharmacy Practice Research Award.

Grants

• Brandon Collins: Schnucks Pharmacy, DSME Site Accreditation Grant.
• Jennie Jarrett: ACCP Am Care PRN Innovations Award 2019.

Publications

• Anderson SL, Marrs JC. Chronic obstructive pulmonary disease. In: Schwinghammer TL, Koehler JM, eds. Pharmacotherapy Casebook: A Patient-Focused Approach, 11th ed. New York: McGraw-Hill. In press.
• Anderson SL, Marrs JC. Can direct oral anticoagulants be used for stroke prevention among patients with valvular atrial fibrillation? Curr Cardiol Rep 2019. In press.
• Anderson SL, Trujillo JM. Type 2 diabetes. In: McDermott MT, ed. Endocrine Secrets, 7th ed. Philadelphia: Elsevier, 2019:31-42.
• Courtney L, Anderson SL, Marrs JC. Lipid lowering therapy for primary prevention in the HIV patient. LipidSpin 2019;17(2).
• Arnold LM, Pande AN. Pharmacologics: systemic and transcatheter therapies. In: Kim D, Patel N, Farber A, eds. Vascular Imaging and Endovascular Intervention. New Delhi: Jaypee Brothers, 2019:chap 10.
• Long MT, Ko D, Arnold LM, et al. Gastrointestinal and liver diseases and atrial fibrillation: a review of the literature. Ther Adv Gastroenterol 2019;12:1-19.
• Migliozzi DR, Asal NJ. Clinical controversy in transplantation: tacrolimus versus cyclosporine in statin drug interactions. Ann Pharmacother 2019 Aug 23. [Epub ahead of print]
• Boylan PM, Santibanez M. Upper gastrointestinal bleeding in a male patient taking megestrol acetate and rivaroxaban: a case report. Sr Care Pharm 2019;34:501-9.
• Boylan PM, Sedlacek J, Santibanez M, et al. Development and implementation of interprofessional relations between a college of pharmacy and osteopathic residency programs in a community teaching hospital. J Pharm Technol 2019 Jul 22. [Epub ahead of print]
• Ebied A, Antigua A. Evaluation of the concurrent use of lidocaine and ketamine infusions as adjunctive analgesia in the intensive care unit. J Res Pharm 2019;23:617-20.
• Ebied AM, Li T, Axelrod S, et al. Intravenous unfractionated heparin dosing in obese patients using anti-Xa levels. J Thromb Thrombolysis 2019 Sep 5. [Epub ahead of print]
• Ebied AM, Na J, Cooper-DeHoff RM. New drug approvals in 2018 – another record year! Am J Med 2019 Mar 7. [Epub ahead of print]
• Fernandez EV, Reid JC Woodward LM, Holdford DA, Gravatt LAH, et al. Implementation of an interviewing skills workshop for pharmacy students. Curr Pharm Teach Learn 2019;11:277-86.
• Jarrett JB, Antoun J, Hasnain M. Entrustable professional activity utilization: a CERA study of family medicine residency program directors. Fam Med 2019;51:471-6.
• Pham JT, Azzopardi LM, Lau AH, Jarrett JB. Student perspectives on a collaborative international doctorate of pharmacy program. Pharmacy (Basel) 2019;7(3).
• Roberson KY, Van Gompel EW, Jarrett JB. Bariatric surgery + medical therapy: effective Tx for T2DM? J Fam Pract 2019;68:102-4.
• Brown CB, Manis MM, Bohm NM, et al. Oral vancomycin for secondary prophylaxis of Clostridium difficile infections. Ann Pharmacother 2019;53:396-401.
• Seymore RJ, Manis MM, Coyne PJ. Dexmedetomidine use in a case of severe cancer pain. J Pain Palliat Care Pharmacother 2019:1-8.
• March KL, Twilla JD, Reaves AB, et al. Lorazepam versus chlordiazepoxide for the treatment of alcohol withdrawal syndrome and prevention of delirium tremens in general medicine ward patients. Alcohol 2019 Jun 6. [Epub ahead of print]
• Marrs JC, Anderson SL. Heart failure with preserved ejection fraction (HFpEF). In: Schwinghammer TL, Koehler JM, eds. Pharmacotherapy Casebook: A Patient-Focused Approach, 11th ed. New York: McGraw-Hill. In press.
• Moore DC, Gebru T, Muslimani A. Fostamatinib for the treatment of immune thrombocytopenia. Am J Health Syst Pharm 2019;76:789-94.
• Moore DC, Gebru T, Pellegrino A, et al. Neutropenia-associated outcomes in breast cancer patients receiving myelosuppressive chemotherapy with reduced doses of pegfilgrastim. J Pharm Pract 2019 Mar 27. [Epub ahead of print]
• Arnall JR, Moore DC, Hill HL, et al. Enhancing the feasibility of outpatient daratumumab administration via a split-dosing strategy with initial doses. Leuk Lymphoma 2019 Mar 8. [Epub ahead of print]
• Patel J, Rainess RA, Benfield MJ, Roger KM, Moore DC, et al. Retrospective analysis of clinical outcomes associated with the use of pegfilgrastim on-body injector in patients receiving chemotherapy requiring granulocyte colony-stimulating factor support. Hosp Pharm 2019 Aug 2. [Epub ahead of print]
• Murphy JA, Heisser JM, Montgomery M. Evidence-based review of smart phone versus paper asthma action plans on asthma control. J Pharm Technol 2019;35:126-34.
• Patel KS, Carbone A. Sodium-glucose cotransporters as potential therapeutic targets in patients with type 1 diabetes mellitus: an update on phase 3 clinical trial data. Ann Pharmacotherapy 2019 Jun 21. [Epub ahead of print]
• Yang T, Ruegger M, Colavecchia AC, Sadhu A, Patham B, Tatara A. Comparison of levothyroxine dosing in patients with and without heart failure. Endocr Res 2019:1-8.
• Soric MM, Paxos C, Dugan SE, et al. Prevalence and predictors of benzodiazepine monotherapy in patients with depression: a national cross-sectional study. J Clin Psychiatry 2019;80(4).
• Soric MM, Robinson JD, Ulbrich TR. A need for a holistic residency application review process. J Am Coll Clin Pharm 2019;2:321.
• Frost DA, Soric MM, Kaiser R, et al. Efficacy of tramadol for pain management in patients receiving strong cytochrome P450 2D6 inhibitors. Pharmacotherapy 2019;39:724-9.
• Snyder BM, Soric MM. National trends in statin medication prescribing in patients with a history of stroke or transient ischemic attack. J Pharm Pract 2019 Jul 21. [Epub ahead of print]

New ACCP Fellows

• Jennie B. Jarrett
• Mate M. Soric
• Jennifer Twilla

Other Notable Achievements

• Sarah L. Anderson: Finalist; Next-Generation Pharmacist Health-System Pharmacist Award (award winner will be announced in late October 2019).
• Nicole Asal: Completed year as President of the Rhode Island Pharmacists Association (2018–2019).
• Alex Ebied: ID Stewardship Interview – Insights into Non-traditional Doctor of Pharmacy Programs.

Promotions

• Laura Challen: Associate Professor, St. Louis College of Pharmacy.
• Gabriella Douglass: Associate Professor, Harding University College of Pharmacy.
• Roshni Emmons: Associate Professor of Pharmacy Practice, Jefferson College of Pharmacy.
• Justinne Guyton: Associate Professor, St. Louis College of Pharmacy.
• Adriane Irwin: Associate Professor (Clinical), Oregon State University/Oregon Health & Science University College of Pharmacy.
• Diana N. Nowicki: Anticoagulation Ambulatory Clinical Pharmacist and now member of AAHIVM Great Lakes Steering Committee.
• Rochelle Rubin: Assistant Director, Ambulatory Pharmacy Services, Lahey Hospital & Medical Center.
• Laura Traynor: Professor, Concordia University School of Pharmacy.
• Ryan Wargo: Ambulatory Clinic Pharmacist Manager, Legacy Health.
• Sarah Westberg: Professor, University of Minnesota College of Pharmacy.

Awards

• Mary Amato: MCPHS University – Faculty Scholarship Award for Scholarship of Discovery – May 2019.
• Diana Isaacs: American Association of Diabetes Educators (AADE) Diabetes Educator of the Year.
• Shannon Miller: Faculty Recognition Award, University of Florida College of Pharmacy, 2019; Outstanding Teaching Team University of Florida College of Pharmacy, 2019.
• Mary Beth O’Connell: Phi Lambda Sigma Leadership Society Gamma Chi Chapter Honorary Member; Runner-up Chapter of the Year, Lambda Kappa Sigma Professional Fraternity; Adviser.
• Mate M. Soric: Class of 2019 Most Influential Professor; Class of 2019 Commencement Hooder; Ohio Society of Health-System Pharmacists Pharmacy Practice Research Award.
• Lisa M. Woolard: Georgia Society of Health-System Pharmacists Outstanding Pharmacy Practitioner Award.
• Cheng Yuet: Texas Society of Health-System Pharmacists (TSHP) Innovative Clinical Practice Award 2019; University of North Texas System College of Pharmacy APPE Faculty Preceptor of the Year 2018–2019.

Grants

• Kelly Cochran: HRSA Medical Student Education Program: An Innovative Model to Increase Primary Care Physicians for Rural and Underserved Missouri.
• Lucas Hill: Texas Targeted Opioid Response via Substance Abuse and Mental Health Services Administration.
• Eric Ip: Touro University California Intramural Research Award Program (IRAP) Grant (July 2019).
• Jennie Jarrett: ACCP Ambulatory Care PRN Innovations Award 2019.
• Linid Lewis: 2019 HealthTrust Innovation Grant.
• Michelle T. Martin, Rodrigo M. Burgos, Renata O. Smith. Sarah M. Michienzi (principal investigator). Cohort Study of Hepatitis C Virus Treatment with Zepatier (elbasvir/grazoprevir) in Genotype 1 or 4 HCV Treatment-Naive or Peginterferon/ribavirin-Experienced Patients with Substance Use in Urban, Multidisciplinary Specialty Clinics. Investigator-sponsored research. Funded by: Merck.
• Cheng Yuet: University of North Texas System College of Pharmacy New Stage Investigators Research Program Seed Grant (July 2019).

Publications

• Salazar A, Karmiy S, Forsythe K, Amato M, et al. How often do prescribers include indications in drug orders? Analysis of 4 million outpatient prescriptions. Am J Health Syst Pharm 2019;76:970-9.
• Garabedian PM, Wright A, Newbury I, Volk L, Salazar A, Amato M, et al. Comparison of a prototype for indications-based prescribing with 2 commercial prescribing systems. JAMA Network Open 2019;2:e191514.
• Wright A, McEvoy DS, Aaron S, McCoy AB, Amato M, et al. Structured override reasons for drug-drug interaction alerts in electronic health records. J Am Med Inform Assoc 2019;26:934-42.
• Anderson SL, Marrs JC. Can direct oral anticoagulants be used for stroke prevention among patients with valvular atrial fibrillation? Curr Cardiol Rep. In press.
• Anderson SL, Marrs JC. Chronic obstructive pulmonary disease. In: Schwinghammer TL, Koehler JM, eds. Pharmacotherapy Casebook: A Patient-Focused Approach, 11th ed. New York: McGraw-Hill. In press.
• Anderson SL, Trujillo JM. Type 2 diabetes. In: McDermott MT, ed. Endocrine Secrets, 7th ed. Philadelphia: Elsevier, 2019:31-42.
• Courtney L, Anderson SL, Marrs JC. Lipid lowering therapy for primary prevention in the HIV patient. LipidSpin 2019;17(2).
• Marrs JC, Anderson SL. Heart failure with preserved ejection fraction (HFpEF). In: Schwinghammer TL, Koehler JM, eds. Pharmacotherapy Casebook: A Patient-Focused Approach, 11th ed. New York: McGraw-Hill. In press.
• Farhat NM, Farris KB, Patel MR, et al. Comprehensive medication reviews: optimal delivery setting and recommendations for quality assessment. J Am Pharm Assoc (2003) 2019;59:642-5.
• Farhat NM, Vordenberg SE, Marshall VD, et al. Evolution of interdisciplinary geriatric transitions of care on readmission rates. Am J Manag Care 2019;25:e219-e223.
• Gunning K, Kiraly B, Pippitt K. Lice and scabies: treatment update. Am Fam Physician 2019;99:635-42.
• McAdam-Marx C, Tak C, Petigara T, Jones NW, Yoo M, Briley MS, Gunning K, et al. Impact of a guideline-based best practice alert on pneumococcal vaccination rates in adults in a primary care setting. BMC Health Serv Res 2019;19:474.
• Tak CR, Kessler LT, Scott MA, Gunning KN. Pharmacist-prescribed hormonal contraception: a review of the current landscape. J Am Pharm Assoc (2003) 2019;59:633-41.
• Hill LG, Evoy KE, Reveles KR. Pharmacists are missing an opportunity to save lives and advance the profession by embracing opioid harm reduction. J Am Pharm Assoc (2003) 2019 Aug 8. [Epub ahead of print]
• Hill LG, Laguado SA. Guidance for male mentors to support the safety and success of female mentees. Am J Pharm Educ 2019 Jun 25. [Epub ahead of print]
• Hill LG, Steiker LH, Mazin L, et al. Implementation of a collaborative model for opioid overdose prevention on campus. J Am Coll Health 2019 Jan 7. [Epub ahead of print]
• Ip EJ, Doroudgar S, Lau B, et al. Anabolic steroid users’ misuse of non-traditional prescription drugs. Res Social Adm Pharm 2019;15:949-52.
• Irwin AN, Stewart OC, Nguyen VQ, et al. Public perception of pharmacist-prescribed self-administered non-emergency hormonal contraception: an analysis of social media comments. Res Social Adm Pharm 2019;15:650-5.
• Hartung DM, Johnston K, Irwin AN, et al. Trends in coverage for disease-modifying therapies for multiple sclerosis in Medicare Part D. Health Aff (Millwood) 2019;38:303-12.
• Walsh S, Irwin AN, Anderson L, et al. Development of a pharmacist-provided contraceptive service following passage of Oregon House Bill 2879. J Am Pharm Assoc (2003). 2019;59(4 suppl):S112-6.
• Isaacs D. 2019 Type 2 diabetes treatment update. Pharm Tech Top 2019;24(2).
• Isaacs D, Bzowyckyj A. New medications on the horizon for diabetes. AADE Pract. May 2019.
• Jarrett JB, Antoun J, Hasnain M. Entrustable professional activity utilization: a CERA study of family medicine residency program directors. Fam Med 2019;51:471-6.
• Pham JT, Azzopardi LM, Lau AH, Jarrett JB. Student perspectives on a collaborative international doctorate of pharmacy program. Pharmacy (Basel) 2019;7(3).
• Roberson KY, Van Gompel EW, Jarrett JB. Bariatric surgery + medical therapy: effective Tx for T2DM? J Fam Pract 2019;68:102-4.
• Martin MT. HCV screening: how can pharmacists get involved? Clin Care Options Online. May 21, 2019.
• Martin MT. Hepatitis C virus management in the post-pipeline era. In: Dixon DL, Harris IM, eds. Ambulatory Care Self-Assessment Program, 2019 Book 2. Infection Primary Care. Lenexa, KS: American College of Clinical Pharmacy, 2019:7-28.
• Martin MT. Gastrointestinal disorders. In: Bainbridge JL, Cardone K, Cross LB., et al., eds. ACCP/ASHP 2019 Ambulatory Care Pharmacy Preparatory Review and Recertification Course. Lenexa, KS: American College of Clinical Pharmacy, 2019:983-1091.
• Koren DE, Zuckerman A, Teply R, Nabulsi NA, Lee TA, Martin MT. Expanding hepatitis C virus care and cure: national experience using a clinical pharmacist-driven model. Open Forum Infect Dis 2019;6:ofz316.
• Michienzi SM, Martin MT. Hepatitis A, B, and D. In: Dodds Ashley ES, Gross AE, eds. Infectious Diseases Self-Assessment Program, 2019 Book 1. HIV and Hepatitis. Lenexa, KS: American College of Clinical Pharmacy, 2019:85-104.
• Farzaneh M, Puneet G, Miller S, et al. Quantitative approaches in translational cardiometabolic research: an overview. In: Krentz AJ, Heinemann M, Hompesch M, eds. Translational Research Methods for Diabetes, Obesity and Nonalcoholic Fatty Liver Disease. Geneva: Springer, 2019.
• Mills AR, Arnett SJ, Shan M, et al. Perception of immunizations and vaccine recommendation sources for persons living with HIV compared with persons without HIV. J Am Pharm Assoc 2019;59(4 suppl):S39-S46.
• O’Connell MB, Mollon L, Pattin CJ, et al. LGBT, race, ethnicity, religion and cultural sensitivity. In: Women’s Health Across the Lifespan: A Pharmacotherapeutic Approach, 2nd ed. New York: McGraw-Hill, 2019:eChapter AccessPharmacy.
• O’Connell MB, Smith JD. Women’s Health Across the Lifespan: A Pharmacotherapeutic Approach, 2nd ed. Pharmacy textbook on AccessPharmacy.
• Soric MM, Paxos C, Dugan SE, et al. Prevalence and predictors of benzodiazepine monotherapy in patients with depression: a national cross-sectional study. J Clin Psychiatry 2019;80:18m12588.
• Soric MM, Robinson JD, Ulbrich TR. Grade point average is an inappropriate measure of a residency candidate’s knowledge and skills. J Am Coll Clin Pharm 2019;2:177-80.
• Soric MM, Robinson JD, Ulbrich TR. A need for a holistic residency application review process. J Am Coll Clin Pharm 2019;2:321.
• Frost DA, Soric MM, Kaiser R, et al. Efficacy of tramadol for pain management in patients receiving strong cytochrome P450 2D6 inhibitors. Pharmacotherapy 2019;39:724-9.
• Snyder BM, Soric MM. National trends in statin medication prescribing in patients with a history of stroke or transient ischemic attack. J Pharm Pract 2019 Jul 21. [Epub ahead of print]
• Wheeler SE, Sevin Valentino A, Liston BW, et al. A team-based learning approach to interprofessional education of medical and pharmacy students. Curr Pharm Teach Learn 2019. In press.

New Fellows

• Jennie Jarrett
• Christie Schumacher
• Mate M. Soric

Other Notable Achievements

• Sarah L. Anderson: Finalist; Next-Generation Pharmacist Health-System Pharmacist award (winner to be announced October 2019).
• Karen Gunning: Chair-Elect of the Board of Directors of the Board of Pharmacy Specialties (BPS); Named to the Utah Board of Pharmacy.
• Nathan A. Painter: Clinical Professor of Pharmacy, University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences.
• Marissa C. Salvo:Fellow of the Connecticut Pharmacists Association (induction September 2019).

Promotions

• Rob J. DiDomenico Jr: Named Interim Assistant Head of Pharmacy Practice, University of Illinois at Chicago, College of Pharmacy.
• Caitlin M. Gibson: Associate Professor and Vice Chair, Department of Pharmacotherapy, University of North Texas System College of Pharmacy.
• Ian B. Hollis: Associate Professor of Clinical Education, Division of Practice Advancement and Clinical Education (PACE), University of North Carolina Eshelman School of Pharmacy (May 2019).
• Carleton Maxwell: Named Clinical Pharmacy Manager at Atrium Health.
• Emily Young: Residency Program Director for the PGY2 Cardiology Pharmacy Residency at VA Tennessee Valley Healthcare System (Nashville, Tennessee).

Awards

• Sally Arif: 2019 Teacher of the Year, Midwestern University, Chicago College of Pharmacy.
• Jenna Cox: South Carolina Society of Health-System Pharmacists, Pharmacist of the Year (March 2019).
• Lindsay E. Davis: Teacher of the Year, Midwestern University College of Pharmacy – Glendale Class of 2019.
• Catherine Derington: Fellow participant at the American Heart Association Ten-Day Seminar on the Epidemiology and Prevention of Cardiovascular Disease.
• Caitlin M. Gibson: University of North Texas Health Science Center 2019 Faculty Achievement Award.
• Carleton Maxwell: 2018–2019 Residency Preceptor of the Year – Carolinas Medical Center.
• Emily Young: Named Preceptor of the Year for 2018–2019 VA Tennessee Valley Healthcare System’s PGY1 Pharmacy Residency Program (Nashville, Tennessee).

Grants

• Jim Coons: Precision Medicine Pilot Award Program, University of Pittsburgh Institute for Precision Medicine, “Whole Genome Sequencing to Explore Variability in Treprostinil Response in Patients with Pulmonary Arterial Hypertension.” Role: principal investigator; 2019–2020.
• Catherine Derington: American Heart Association Post-Doctoral Fellowship Grant.
• Genevieve Hale: Hale G (principal investigator), Lymperopoulos A, Joseph T, Simpson A, Zorrilla R, Kankam E, Choudhry A, Wertz S, Pollard C. Arg389Gly Polymorphism in Beta-1 Adrenoceptors for Heart Failure Patients Within the Primary Care Setting. April 2019. NSU President’s Faculty Research and Development Grant. $13,740.00.
• James Tisdale: AHRQ R18 – Dissemination and Implementation of QT Risk Clinical Decision Support (co-investigator).
• Toby Trujillo:
  

  Aspirin Dosing Estimator in Healthy Adult. Funded by: Skaggs Scholars Program (co-primary investigator), total grant $150,000. Funding period: 2019–2021.

  The Evaluation of a Kcentra Fixed-Dose Protocol: Retrospective Pre-vs Post-Institutional Experience. Funded by: CSL Pharmaceuticals (co-investigator), total grant $32,449.00. Funding period: January 2019 – January 2020.

Publications

• Kaye AB, Bhakta A, Moseley AD, Rao AK, Arif S, et al. Review of cardiovascular drugs in pregnancy. J Womens Health 2019;28:686-97.
• Arif SA, Tran T. Deep venous thrombosis. In: Schwinghammer TL, Koehler JM, Borchert JS, Park S, Slain DS, eds. Pharmacotherapy Casebook: A Patient-Focused Approach, 11th ed. New York: McGraw-Hill, 2019.
• Atallah B, Sadik ZG, Hisham M, et al. A per-protocol initiation of sacubitril/valsartan in an advanced heart failure disease management programme in the Middle East Gulf region. ESC Heart Fail 2019;6:758-63.
• Baker WL, Steiger S, Radojevic J, et al. Association between time-in-therapeutic tacrolimus range and early rejection after heart transplant. Pharmacotherapy 2019;39:609-13.
• Dixon DL, Baker WL. Correlation of altmetric attention scores with citations in major pharmacy journals. J Am Coll Clin Pharm. In press.
• Coleman CI, Weeda ER, Kharat A, Bookhart B, Baker WL. Impact of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and mortality outcomes in patients with type 2 diabetes and proteinuria. Diabetes Med. In press.
• Kunkes JH, Baker WL, Gluck JA. Vasopressin: perspectives and applications after cardiac surgery. J Card Surg 2019;34:20-7.
• Martinez BK, Baker WL, Konopka A, et al. Systematic review and meta-analysis of catheter ablation of ventricular tachycardia in ischemic heart disease. Heart Rhythm 2019 Apr 27. [Epub ahead of print]
• Patel N, Patel K, Shenoy A, Baker WL, et al. Cryoballoon ablation for the treatment of atrial fibrillation: a meta-analysis. Curr Cardiol Rev 2019;15:230-8.
• Sobieraj DM, Martinez BK, Hernandez AV, Coleman CI, Ross JS, Berg KM, Steffens DC, Baker WL. Adverse effects of pharmacologic treatments of major depression in older adults. J Am Geriatr Soc 2019;67:1571-81.
• Beavers JC, Mithawala P. Ironing it out: management of iron deficiency in heart failure. Cardiol Today. November 2018.
• Lopez C, Buckley L, Aldemerdash A. Will an aspirin a day keep MI away? New evidence, recommendations from the ACC/AHA. New guideline gives aspirin a downgrade. Cardiol Today. May 2019.
• Kim K, Ardati A,Cavallari L, Touchette DR, DiDomenico RJ. Cost-effectiveness of genotype/phenotype driven ticagrelor versus clopidogrel selection in patients with acute coronary syndrome. Cardiovasc Drug Ther 2019.
• Coons JC, Benedict N, Seybert AL, et al. Pharmacotherapy scholars program: intensive longitudinal training to enhance post-graduate readiness. Am J Pharm Educ 2019. In press.
• Coons JC, Iasella CJ, Thornberg M, et al. Clinical outcomes with unfractionated heparin monitored by anti-factor Xa vs. activated partial thromboplastin time. Am J Hematol 2019;94:1015-9.
• Crisamore K, Nolin TN, Coons JC, et al. Engaging and empowering stakeholders to advance pharmacogenomics. Clin Pharmacol Ther 2019;106:305-8.
• Hicks JK, Aquilante CL, Dunnenberger HM, Gammal RS, Funk RS, Aitken SL, Bright DR, Coons JC, et al; on behalf of the 2019 ACCP Clinical Practice Affairs Committee. Precision pharmacotherapy: integrating pharmacogenomics into clinical pharmacy practice. J Am Coll Clin Pharm 2019;2:303-13.
• Iasella CJ, Kreider MS, Huang L, Coons JC, et al. Effect of selective serotonin reuptake inhibitors on cardiovascular outcomes after percutaneous coronary intervention: a retrospective cohort study. Clin Drug Investig 2019;39:543-51.
• Seybert AL, Smithburger PL, Benedict NJ, Kobulinsky LR, Kane-Gill SL, Coons JC. Evidence for simulation in pharmacy education. J Am Coll Clin Pharm 2019 Jul 26. [Epub ahead of print]
• Lim J, Cox JF, Nguyen T, et al. Cisatracurium dosing in a patient with hyperthermia. Am J Health Syst Pharm 2019;76:1029-32.
• Dager WE, Roberts AJ, Nishijima DK. Effect of low and moderate dose FEIBA to reverse major bleeding in patients on direct oral anticoagulants. Thromb Res 2019;173:71-6.
• Dager WE, Walker EA, Roberts AJ. Bivalirudin in extracorporeal life support: response and considerations. ASAIO J 2019;65:e54.
• Hoff BM, Maker JH, Dager WE, et al. Antibiotic dosing for critically ill adult patients receiving intermittent hemodialysis, prolonged intermittent renal replacement therapy, and continuous renal replacement therapy: an update. Ann Pharmacother 2019 Jul 25. [Epub ahead of print]
• Davis LE. Atrial fibrillation. Pharmacotherapy First: A Multimedia Learning Resource. 2019.
• Larson S, Davis LE, Stevens A, et al. Development of a tool to assess and advance the effectiveness of preceptors: the habits of preceptors rubric. Am J Health Syst Pharm 2019. In press.
• Pogge EK, Raney E, Jackowski R, Larson S, Storjohann T, Davis LE. Evaluation of a teaching and learning curriculum for preceptors and residents. J Am Coll Clin Pharm 2019;1-8.
• Derington CG, Gums TH, Bress AP, et al. Association of total medication burden with intensive and standard blood pressure control and clinical outcomes: a secondary analysis of the Systolic Blood Pressure Intervention Trial (SPRINT). Hypertension 2019;74:267-75.
• Derington CG, Lopez BR, Weber RJ, et al. Comparison of 3 surveillance methods to detect potential controlled substance diversion in an academic medical center. Hosp Pharm 2019 Apr 29. [Epub ahead of print]
• Owlia M, Dodson JA, King JB, Derington CG, et al. Angina severity, mortality, and healthcare utilization among veterans with stable angina. J Am Heart Assoc 2019;8:e012811.
• Prieto-Centurion V, Basu S, Bracken N, Calhoun E, Dickens C, DiDomenico RJ, Gallardo R, Gordeuk V, Gutierrez-Kapheim M, Hsu L, Illendula S, Joo M, Kazmi U, Mutso A, Pickard AS, Pittendrigh B, Sullivan JL, Williams M, Krishnan JA. Design of the Patient Navigator to Reduce Readmissions (PArTNER) study: a pragmatic clinical effectiveness trial. Contemp Clin Trials Commun 2019.
• Dobesh PP, DiDomenico RJ, Rogers KC. Stable ischemic heart disease. In: DiPiro JT, Yee GC, Posey LM, Haines ST, Nolin TD, Ellingrod V, eds. Pharmacotherapy: A Pathophysiologic Approach, 11th ed. New York: McGraw-Hill, 2019:chap 32.
• Gasbarro NM, DiDomenico RJ. Frequency of “on-label” use of intravenous diltiazem for rate control in patients with acute-onset atrial fibrillation or atrial flutter. Am J Health Syst Pharm 2019;76:214-20.
• Gibson CM, Howard ML. The evolving role of direct oral anticoagulants in cardiovascular disease: a review of recent literature. TSHP J 2019;18:9-11.
• Gibson CM, Kwon HI, Tatachar A. Impact of a low-cost simulated electronic medical record on perceptions of APPE readiness. Curr Pharm Teach Learn 2019;11:736-41.
• Blizzard S, Verbosky N, Stein BJ, Hale G, et al. Evaluation of pharmacist impact within an interdisciplinary inpatient heart failure consult service. Ann Pharmacother 2019;53:905-15.
• Kido K, Coons JC. Efficacy and safety of pulmonary arterial hypertension medications in patients with pulmonary hypertension due to left heart disease. Pharmacotherapy 2019;39:929-45.
• Kido K, Shimizu M, Hashiguchi M. Comparing torsemide versus furosemide in patients with heart failure: a meta-analysis. J Am Pharm Assoc (2003). 2019;59:432-8.
• Klein MD, Williams AK, Lee CR, et al. Clinical utility of CYP2C19 genotyping to guide antiplatelet therapy in patients with an acute coronary syndrome or undergoing percutaneous coronary intervention. Arterioscler Thromb Vasc Biol 2019;39:647-52.
• Martin J, Williams AK, Klein MD, Sriramoju VB, Madan S, Clarke M, Cicci JD, Rossi JS, Cavallari LH, Weck KE, Stouffer GA, Lee CR. Frequency and clinical outcomes of CYP2C19 genotype-guided escalation and de-escalation of antiplatelet therapy in a real-world clinical setting. Genet Med 2019 Jul 18. [Epub ahead of print]
• Williams AK, Klein MD, Martin J, Weck KE, Rossi JS, Stouffer GA, Lee CR. CYP2C19 genotype-guided antiplatelet therapy and thirty-day outcomes after percutaneous coronary intervention. Circ Genom Precis Med 2019;12:e002441.
• Littlefield AJ, Ciolek AM. Do not go with the flow: stemming the tide of GI bleeding with continuous-flow VADs. Cardiol Today. October 2018.
• McConnell KJ. 2018 ACC/AHA guidelines for cholesterol management in adult patients. Pharm Today 2019;25:46-58.
• Milfred-LaForest, Sharon K. Transitions of care in heart failure. In: Page RL, ed. ACCP Self-Assessment Program, Cardiology Specialty Board Certification – Heart Failure Module Book 1. American College of Clinical Pharmacy.
• Ng T, DiDomenico RJ, Ripley TL, Benge CD, Buckley L, Campbell KB, Hale G, Macaulay TE, Nappi J, Pickworth K, Short M. An opinion paper of the American College of Clinical Pharmacy Cardiology Practice and Research Network outlining recommendations for training of cardiovascular pharmacy specialists in post-graduate year 2 residency programs. J Am Coll Clin Pharm 2019;1-14.
• Adie S, Bitar A, Hanigan S, Pogue K, et al. Real-world prevalence of adverse events after initiating sacubitril/valsartan compared to angiotensin converting enzyme inhibitors or angiotensin receptor blockers in systolic heart failure. J Card Fail 2019;25:412-3.
• Rollins A, Hanigan S, Pogue K, et al. Identifying clinical predictors of switching from direct oral anticoagulants to warfarin. Clin Med Insights 2019;11:1-6.
• Smith ZR, Rangarajan K, Barrow J, Carter D, Coons JC, Dzierba AL, Falvey J, Fester KA, Guido MR, Hao D, Ou NN, Pogue KT, et al. Development of best practice recommendations for the safe use of pulmonary hypertension pharmacotherapies using a modified Delphi method. Am J Health Syst Pharm 2019;76:153-65.
• Reed BN, DiDomenico RJ, Allender JE, Coons JC, Cox JF, Johnson D, Oliphant CS, Jennings DL. Survey of anticoagulation practices with the Impella percutaneous ventricular assist device at high-volume centers. J Interv Cardiol 2019:Article 3791307.
• Rogers KC, Finks SW. A new option for reversing the anticoagulant effect of factor Xa inhibitors: andexanet alfa (Andexxa®). Am J Med 2019;132:38-41.
• Rogers KC, Neu DW, Jaeger MC, Shah R, Finks SW. An underappreciated and prolonged drug interaction leads to ineffective anticoagulation. So Med J 2019;112:125-9.
• Schwier NC. Pharmacists’ role in the management of acute and recurrent pericarditis: inpatient and outpatient perspectives. J Pharm Pract 2019 Jun 25. [Epub ahead of print]
• Schwier NC. Βeta-blocker therapy in cocaine-associated heart failure: attempting to mitigate the risk. Int J Cardiol 2019;283:135.
• Schwier NC, Cornelio CK, Epperson T. Acute and recurrent idiopathic (viral) pericarditis. JAAPA 2019. In press.
• Cannedy JJ, Skrepnek GH, Schwier NC. Management of acute idiopathic (viral) pericarditis in the emergency department: a review for the nursing professional. AENJ 2019. In press.
• Fox AN, Skrepnek GH, Miller JL, Schwier NC, et al. Optimal medical therapy prescribing patterns and disparities identified in patients with acute coronary syndromes at an academic medical center in an area with high coronary heart disease-related mortality. Am J Cardiovasc Drugs 2019;19:185-93.
• McQueen CE, Smith A. Cardiovascular disease. In: Hume A, Orr K, eds. Principles and Practice of Botanicals as an Integrative Therapy. London: Taylor & Francis, April 2019.
• Spencer D. Ultrasound-assisted, catheter-directed therapy for pulmonary embolism: breaking down the evidence. Cardiol Today. March 2019.
• Tisdale JE. Arrhythmias. In: Baker WL, Bolesta S, Coons JC, Cooper-DeHoff RM, Dixon DL, Dobesh PP, Dunn SP, Finks SW, Jennings DL, Macaulay TE, McConnell KJ, Oliphant CS, Page RL II, Parker MH, Reed BN, Rogers KC, Sowinski KM, Spencer DD, Tisdale JE, eds. 2019 Cardiology Pharmacy Preparatory Review and Recertification Course, 2019 ed. Lenexa, KS: American College of Clinical Pharmacy, 2019:211-94.
• Tisdale JE. Editorial commentary. Amiodarone-induced thyroid diseases: additional unintended consequences. Trends Cardiovasc Med 2019;29:296-7.
• Tisdale JE. Proarrhythmic food for thought. Heart Rhythm 2019;16:1149-50.
• Tisdale JE. Jaynes HA, Overholser BR, et al. Progesterone pretreatment reduces the incidence of drug-induced torsades de pointes in atrioventricular node-ablated isolated perfused rabbit hearts. J Cardiovasc Electrophysiol 2019;30:941-9.
• Tisdale JE, Jaynes HA, Watson MR, et al. Amiodarone for prevention of atrial fibrillation following esophagectomy. J Thorac Cardiovasc Surg 2019;158:301-10.
• Kovacs RJ, Birtcher KK, Tisdale JE. Pharmacists and cardiologists in the ACC. J Am Coll Cardiol 2019;74:470-2.
• Zarowitz BJ, Tisdale JE. Navigating the minefield of QTc interval-prolonging therapy in nursing facility residents. J Am Geriatr Soc 2019;67:1508-15.
• Trujillo TC, Dobesh PP, Crossley G, Finks SW. Contemporary management of direct oral anticoagulants during cardioversion and ablation for non-valvular atrial fibrillation. Pharmacotherapy 2019;39:94-108.
• Valente M, Faulkenberg K. Out of the loop: augmenting diuresis with SGLT2 inhibitors in heart failure. Cardiol Today. July 2019.
• Van Tuyl JS, Newsome AS, Hollis IB. Perioperative bridging with glycoprotein IIb/IIIa inhibitors versus cangrelor: balancing efficacy and safety. Ann Pharmacother 2019;53:726-37.
• Walker EA, Roberts AJ, Louie EL, Dager WE. Bivalirudin dosing requirements in adult patients on extracorporeal life support with or without continuous renal replacement therapy. ASAIO J 2019;65:134-8.
• Herink MC, Zhuo YF, Williams CD, et al. Clinical management of pharmacokinetic drug interactions with direct oral anticoagulants (DOACs). Drugs. August 22, 2019.
• Xiong L, Chinaeke E, Lu K, et al. Evaluation of severe myalgia induced by continuous-infusion bumetanide in patients with acute heart failure. Pharmacotherapy 2019;39:854-60.

New ACCP Fellows

• Christie Schumacher

Other Notable Achievements

• William E. Dager: Reelected as Regent – American College of Critical Care Medicine; 2019 SCCM Congress Co-Chair.
• William R. Dager: Second-generation ACCP Cardiology PRN Student Member (William E. Dager – father).
• Catherine Derington: Board Certified Ambulatory Care Pharmacist (BCACP).
• Ian B. Hollis: Vice Chair of the BPS Specialty Council on Cardiology Pharmacy for 2020.
• Carleton Maxwell: Fellow of the National Pharmaceutical Association (FNPhA).
• Karen J. McConnell: Fellow of the American Society of Health-System Pharmacists (FASHP); Official content peer reviewer for the 2018 ACC/AHA Cholesterol Clinical Practice Guidelines.
• Kerry Pickworth: Appointed to the ASHP Commission on Credentialing for Residency accreditation for a 3-year team.
• Kristen T. Pogue: Selected to the BPS Cardiology Specialty Council.

Board Certified Cardiology Pharmacists

The PRN would like to congratulate all who achieved board certification in cardiology during the recent testing period. Thirty-five new members are now BCCPs.

• Sarah K. Adie
• Mohamed Amar
• Ayesha Ather
• Maryam Bayat
• Janna Beavers
• Michael Brenner
• Hope Broxterman
• John J. Cannedy
• Catherine Chun
• John Dechand
• Stephanie M. Dwyer
• Wendy M. Gabriel
• Alexandra Goncharenko
• Laura Halder
• Genevieve M. Hale
• Joshua A. Jacobs
• Oksana Kamneva
• Ashley K. Kasper
• Hasan O. Kazmi
• Amy L. Lehnert
• Hua Ling
• Adrienne Lunde
• Kathleen Makkar
• Rebecca Moore
• Kelsey E. Norman
• Tomasz D. Oszczypala
• Frank S. Rigelsky
• Christina E. Ruggia-Check
• Elisabeth Sulaica
• Huyentran N. Tran
• Dong P. Tu
• Elizabeth A. Walker
• Margaret M. Wovkulich
• Yan Xu
• Nicole G. Zimbardi

Promotions

• Jeannine Conway: Associate Dean of Professional Education at the University of Minnesota College of Pharmacy.

Awards

• Jennifer Bean: Pharmacist of the Year Award from Tennessee Society of Health-System Pharmacists (TSHP).
• Joshua Caballero: Distinguished Alumnus Award from Phi Delta Chi.
• Benjamin Chavez: 2019 Remarkable Provider award from Salud Family Health Centers in Colorado.
• Gary Levin: 2019 Judith J. Saklad award from the College of Psychiatric and Neurologic Pharmacists (CPNP).

Grants

• Stephanie Nichols:
  Preventing Harm and Reducing Maine Overdose Deaths (PHARMOD).
  

  Stephanie Nichols and colleagues from the University of New England College of Pharmacy were awarded $21,000 by the State of Maine to educate Maine pharmacists about opioid overdose, take-home naloxone, and stigma and to improve the proportion of Maine pharmacists who are eligible to prescribe naloxone.

Publications

• Jensen A, Beam C, Douglass A, Brabson J, Colvard M, Bean J. Description of a pharmacist-led clinical video telehealth group clinic for opioid overdose prevention and naloxone education. Ment Health Clin 2019;9:294-7.
• Karst A, Hayes B, Burka A, Bean J, et al. Effect of the Centers for Disease Control and Prevention opioid prescribing guidelines on postsurgical prescribing among veterans. J Am Coll Clin Pharm 2019;2:155-60.
• Jacobs RJ, Caballero J, Parmar J, et al. The role of self-efficacy, flexibility, and gender in pharmacy students’ health information technology readiness. Curr Pharm Teach Learn 2019 Aug 12. [Epub ahead of print]
• Chavez B, Kosirog E. Impact on an integrated psychiatric pharmacy service in a primary care clinic. Ment Health Clin 2019;9:269-74.
• Lopez A, Rey J. Substituted phenethylamine associated mortality: results of a retrospective review of regional medical examiner cases from 2014-2017 [abstract]. Res Adv Psychiatry 2019;6:1-71.
• Lopez A, Rey J. Role of paliperidone palmitate 3-monthly in the management of schizophrenia: insights from clinical practice. Neuropsychiatr Dis Treat 2019;15:449-56.
• Bahr R, Lopez A, Rey JA. Intranasal esketamine (Spravato™) for use in treatment-resistant depression in conjunction with an oral antidepressant. P T 2019;44:340-75.
• Leung JG, Cusimano JM, Kemp M, Gannon JM, Milgrom O, Valcourt SC, Stoklosa JB, Olsufka W, Vickery PB, Nichols SD, et al. Addressing clozapine under-prescribing and barriers to initiation: a psychiatrist, advanced practice provider, and trainee survey. Int Clin Psychopharmacol 2019;34:247-56.
• Simpson KJ, Moran MT, Foster ML, Shah DT, Chung DT, Nichols SD, et al. Descriptive observational study of pharmaceutical and non-pharmaceutical arrests, use, and overdoses in Maine. BMJ Open 2019;9:e027117.
• Peckham AM, Fairman KA, Awanis GJ, et al. High-risk opioid prescribing trends in the outpatient setting prior to issuance of federal guidance. Prev Med Rep 2019;15:100892.
• Peckham AM, Sclar DA. Quantifying gabapentin misuse with opioids. Prim Care Companion CNS Disord 2019;21.
• Peckham AM, Sclar DA. Combined gabapentinoid and opioid use. Ann Intern Med 2019;170:908-9.
• Evoy KE, Covvey JR, Peckham AM, et al. Reports of gabapentin and pregabalin abuse, misuse, dependence, or overdose: an analysis of the Food and Drug Administration Adverse Events Reporting System (FAERS). Res Social Adm Pharm 2019;15:953-8.

Other Notable Achievements

• Benjamin Chavez: Appointed to the Board of Pharmacy Specialties (BPS) Ambulatory Care Specialty Council.
• Padideh Ghaeli: Delivered a lecture on “Newer Antidepressants” at Roozbeh Hospital affiliated with Tehran University of Medical Sciences (TUMS); Moderated 2 CPCs for TUMS pharmacotherapy residents as a guest clinical pharmacist.
• Janice Hoffman: Delivered a lecture on Leadership Model for Healthcare Teams, University of Vienna Social Change and Aging Conference, September 2019.
• Stephanie Nichols: Appointed to the Maine Opioid Response Clinical Advisory Committee, convened by Governor Janet Mills, July 2019.
• Alyssa M. Peckham: Appointed to the Center for Health Policy & Healthcare Research at Northeastern University in Boston, Massachusetts, as a Faculty Associate; Delivered an ACPE accredited talk titled “Detecting and Managing Opioid Use Disorder in the Setting of Chronic Pain in the Elderly,” Society of Pain and Palliative Care Pharmacists, April 2019; Delivered an ACPE-accredited talk titled “The Pharmacists Role in Increasing Treatment Access for Patients with Opioid Use Disorder,” Massachusetts Society of Health-System Pharmacists, May 2019; Delivered an ACPE-accredited talk titled “Pharmacists as Harm Reductionists,” 2019 Massachusetts Pharmacists Association Summer Event, June 2019; Was featured for ACCP Member Spotlight, ACCP Report, June 2019; Was interviewed by News@Northeastern for “It’s a Chronic Illness Rather than a Moral Failure”; Delivered an ACPE-accredited talk titled “Clearing the Smoke on Cannabis Use Disorder: Prevalence, Neurobiology, and Treatment,” 15th Annual New England Pharmacists Convention, September 2019.

• Eliza A. Dy-Boarman: Associate Professor, Department of Clinical Sciences, Drake University College of Pharmacy and Health Sciences, and Clinical Pharmacist, Iowa Lutheran Hospital. Received the American Association of Colleges of Pharmacy Emerging Teaching Scholar Award in July 2019.
• Christopher Finch: Professor and Chair for the Department of Clinical Pharmacy and Translational Science at the University of Tennessee, College of Pharmacy. Selected as the Tom C. Sharp Pharmacist of the Year by the Tennessee Pharmacists Association.
• Darrel W. Hughes: Clinical Pharmacy Manager and Adjunct Associate Professor in the Department of Pharmacotherapy and Pharmacy Sciences in the University of Texas Health Science Center. Recognized as a Fellow of the American College of Clinical Pharmacy.
• Jeff D. Huntress: Director of Clinical Pharmacy Services, Director of PGY1 Pharmacy Practice Residency, and Critical Care Clinical Specialist at Highland Hospital of the University of Rochester Medical Center. Appointed to the American Society of Health-System Pharmacists Commission on Credentialing.

Promotions

• Brittany Bissell: Assistant Professor, College of Medicine, University of Kentucky Medical Center.
• Chris Finch: Professor and Chair of the Department of Clinical Pharmacy and Translational Science, University of Tennessee, College of Pharmacy.
• Alex Flannery: Associate Adjunct Professor, University of Kentucky.
• Christine Groth: Level IV Clinical Pharmacy Coordinator, Adult Critical Care and Emergency Medicine, University of Rochester Medical Center.
• Jahidul Hasan: Coordinator, Clinical Pharmacy Services, Square Hospitals, Ltd.
• Zachary Smith: Clinical Pharmacy Specialist, Pulmonary Hypertension, Medical Critical Care, Henry Ford Hospital.

Awards

• Scott Bolesta: Presidential Citation Award, Society of Critical Care Medicine.
• Jenna Cox: 2019 Pharmacist of the Year, South Carolina Society of Health-System Pharmacists.
• Chris Droege: Presidential Citation, Society of Critical Care Medicine.
• Chris Finch: Tom C. Sharp Pharmacist of the Year, Tennessee Pharmacists Association.
• Alex Flannery: Star Research Achievement Award, Society of Critical Care Medicine.
• Christine Groth: 2019 Adult Critical Care Excellence in Leadership Award, University of Rochester Medical Center; 2019 Institute for Innovative Education Team-Based Award, Post-Intensive Care Unit Team, University of Rochester Medical Center; 2019 URMC Board Excellence Award-Clinical Support, University of Rochester Medical Center.
• Jahidul Hasan: Alumni Award 2019, Stamford Pharmacy Alumni Association.
• Anthony Hawkins: Teacher of the Year, University of Georgia College of Pharmacy; Critical Care Faculty of the Year, Medical College of Georgia SWGA.
• Judi Jacobi: 2019 Pharmacy Women’s Leadership Award, Pharmacy Women for Purdue.
• Desiree Kosmisky: Presidential Citation, Carolinas/Virginias Chapter of Society of Critical Care Medicine.
• Martin Ohlinger: Distinguished University Lecturer, University of Toledo, April 2019.
• Nick Peters: 2019 Johns Hopkins Clinical Excellence Award – “Innovations in Clinical Care.”

Grants

• Brittany Bissell: Igniting Research Collaborations Grant, University of Kentucky, $25,000.
• Scott Bolesta: Bolesta S. Continued Faculty and Peer-to-Peer Mentored Research in Cardiovascular Science. Submitted March 2019; Wilkes University. Amount requested: $7080 in direct costs. Submitted. Funding period: June 1, 2019 – August 31, 2019. Receiving agency/agent: Wilkes University. Funded for $6550.
• Susan Smith: AACP SOTL Grant.

Publications

• Wright C, Elbadawi A, Chen YL, Mazzillo J, Delehanty J, Patel D, Acquisto NM, Groth C, et al. The impact of a pulmonary embolism response team on the efficiency of patient care in the emergency department. J Thromb Thrombolysis 2019;48:331-5.
• Woodward CW, Lambert J, Ortiz-Soriano V, Li Y, Ruiz-Conejo M, Bissell B, et al. Fluid overload associates with major adverse kidney events in critically ill patients with acute kidney injury requiring continuous renal replacement therapy. Crit Care Med 2019 Jun 3. [Epub ahead of print]
• Bissell BD, Magee C, Moran P, Bastin MLT, Flannery AH. Hemodynamic instability secondary to vasopressin withdrawal in septic shock. J Intensive Care Med 2019;34:761-5.
• Bolesta S. Specialized topics in cardiovascular disease. In: Baker WL, Beavers C, Bolesta S, et al., eds. Updates in Therapeutics®: Cardiology Pharmacy Preparatory Review Course, 2019 ed. Lenexa, KS: American College of Clinical Pharmacy, 2019.
• Boyd AN, Hartman BC, Sood R, et al. A voltage-based analysis of fluid delivery and outcomes in burn patients with electrical injuries over a 6-year period. Burns 2019;45:869-75.
• Anderson GL, Mattson AE, Brown CS, et al. Safety of parental ketorolac use for analgesia in geriatric emergency department patients. Am J Emerg Med 2019. In press.
• Lim J, Cox JF, Nguyen T, et al. Cisatracurium dosing in a patient with hyperthermia. Am J Health Syst Pharm 2019;76:1029-32.
• Cucci M, Wooten C, Mallat A, et al. Incidence and risk factors associated with multi-drug-resistant pathogens in a critically ill trauma population: a retrospective cohort study. Surg Infect (Larchmt) 2019 Jun 17. [Epub ahead of print]
• Rodriguez R, Cucci M, Kane S, et al. Novel vasopressors in the treatment of vasodilatory shock: a systematic review of angiotensin II, selepressin, and terlipressin. J Intensive Care Med 2018 Dec 18. [Epub ahead of print]
• Dasta J, Kane-Gill S. Review of the literature on the costs associated with acute kidney injury. J Pharm Pract 2019;32:292-302.
• Foertsch M, Winter J, Rhoades A, Martin L, Droege CA, et al. Recognition, assessment, and pharmacotherapeutic treatment of alcohol withdrawal syndrome in the intensive care unit. Crit Care Nurs Q 2019;42:12-29.
• Garber PM, Droege CA, Carter KE, et al. Continuous infusion ketamine for adjunctive analgosedation in mechanically ventilated, critically ill patients. Pharmacotherapy 2019;39:288-96.
• Martin LT, Vincent S, Gillian S, Moore K, Ratermann D, Droege CA. Pharmacologic approach to management of Clostridium difficile infection. Crit Care Nurs Q 2019;42:2-11.
• Trobaugh KA, Flannery AH, Thompson Bastin ML. Special populations: transplant and critical care. In: Nemecek B, Hammond D, eds. Demystifying Drug Dosing in Renal Dysfunction. American Society of Health-System Pharmacists, 2019.
• Groth CM. Inhaled antibiotics for respiratory infection. In: Ryu HG, Connor MJ, eds. Current Concepts in Adult Critical Care, 2019. Mount Prospect, IL: Society of Critical Care Medicine, 2019:101-14.
• Hammond DA, Flowers HCJ, Meena NK, Painter JT, Rech MA. Cost avoidance associated with clinical pharmacist presence in a medical intensive care unit. J Am Coll Clin Pharm 2019;1-6.
• Hammond DA, Gurnani PK, Flannery AF, Smetana K, Westrick J, Lat I, Rech MA. Scoping review of interventions associated with cost avoidance able to be performed in the intensive care unit and emergency department. Pharmacotherapy 2019;39:215-31.
• Hammond DA, Lam SW, Rech MA, Smith MN, et al. Balanced crystalloids versus saline in critically ill adults: a systematic review and meta-analysis. Ann Pharmacother 2019 Jul 31. [Epub ahead of print]
• Hammond DA, McCreary EK, Rech MA, Smith MN, Yeo QM, Lusardi K, Rhodes NJ, Swanson J, Bland CM. Perceptions and practices for beta-lactam antibiotic dosing, administration, and monitoring in critically ill patients: current views and use among critical care and infectious diseases pharmacists. J Am Coll Clin Pharm 2019;1-9.
• Hammond DA, Rech MA. How-to guide for effectively performing and coordinating multicenter observational research as a clinical pharmacist. J Am Coll Clin Pharm 2019 Jul 30. [Epub ahead of print]
• Hammond DA, Rech MA, Daley M, Devin J, Hodge E, Kooda K, Lat I, Personett H, Roberts R, Sacha G, Stollings J, Bauer S. Perceptions regarding vasopressin use and practices in septic shock and cost containment strategies. J Am Coll Clin Pharm 2019;2:257-67.
• Hammond DA, Rech MA, Swanson JM. The effect of grit on postgraduate year-one pharmacy residents’ pursuit of additional training. Curr Pharm Teach Learn. Accepted.
• Hammond DA, Sacha G, Bissell B, Musallam N, Altshuler D, Flannery A, Lam S, Bauer S. Effects of norepinephrine and vasopressin discontinuation order in the recovery phase of septic shock: a systematic review and individual patient data meta-analysis. Pharmacotherapy 2019;39:544-52.
• Hammond DA, Smith ME, Peksa GD, et al. Midodrine as an adjuvant to intravenous vasopressor agents in adults with resolving septic shock: systematic review and meta-analysis. J Intensive Care Med 2019 Apr 28. [Epub ahead of print]
• Hammond DA, Trivedi A, Esmero VM, Hamadeh L, Heikkinen B, Tan C, Hanson A, Rech MA. Pharmacists’ perceptions and practice changes resulting from emergence of the vancomycin-piperacillin/tazobactam nephrotoxicity phenomenon. J Am Coll Clin Pharm 2019 Jul 25. [Epub ahead of print]
• Tully AP, Hammond DA, Li C, Jarrell AS, Kruer RM. Evaluation of medication errors at the transition of care from an ICU to non-ICU location. Crit Care Med 2019;47:543-9.
• Hasan MJ, Nizhu LN, Rabbani R. Bloodstream infection with pandrug-resistant Alcaligenes faecalis treated with double-dose of tigecycline. IDCases 2019;18:e00600.
• Hasan MJ, Rabbani R, Bachar SC. Clinical interventions of critical care pharmacist in the therapeutic management of critically ill patients: a retrospective study in Bangladesh. Dhaka Univ J Pharm Sci 2019;18:113-9.
• Hasan MJ, Rabbani R, Bachar SC, et al. High dose tigecycline-induced mitochondrial dysfunction-associated acute metabolic acidosis: a retrospective study. J Mol Genet Med 2019;13:407.
• Hasan MJ, Rabbani R, Huq SMR, et al. Tigecycline in CR-Kp associated VAP with high dose vs. conventional dose: adverse events are the key superiority-determiner. Adv Pharmacoepidemiol Drug Saf 2019;8.227.
• Hawkins WA, Fulford M, Phan SV. Using debates as the primary pedagogy to teach critical care in a PharmD curriculum elective course. Curr Pharm Teach Learn 2019;11(9).
• Hawkins WA, Smith SE, Newsome AS, Carr JR, Bland CM, Branan TN. Fluid stewardship during critical illness: a call to action. J Pharm Pract 2019 Jun 30. [Epub ahead of print]
• Jacobi J. Perspectives on mentorship. SCCM Critical Connections Newsletter, Summer 2019.
• Jacobi J, Czosnowski QA. The effect of critical illness on pharmacokinetics and pharmacodynamics. In: Parillo JE, Dellinger RP, eds. Critical Care Medicine Principles of Diagnosis and Management in the Adult. Philadelphia: Elsevier, 2019.
• Aggarwal MV, Jarrell AS, Gilmore VT, et al. Anti-Xa activity by weight in critically ill patients receiving unfractionated heparin for venous thromboembolism prophylaxis. J Crit Care 2019;52:180-5.
• Lindner BK, Gilmore VT, Kruer RM, Alvanzo AA, Chen ES, Murray P, Niessen T, Perrin K, Rastegar DA, Young S, Jarrell AS. Evaluation of the Brief Alcohol Withdrawal Scale protocol at an academic medical center. J Addict Med 2019 Feb 6. [Epub ahead of print]
• Reardon C, Kane-Gill S, Smithburger PL, Dasta J. Sufentanil sublingual tablet: a new option for acute pain management. Ann Pharmacother 2019;53:1220-6.
• Laine ME, Flannery AH, Moody B, Thompson Bastin ML. Need for expanded Candida score for empiric antifungal use in medically critically ill patients? [letter] Crit Care 2019;23:242.
• Lat I, Daley MJ, Shewale A, Pangrazzi MH, Hammond D, Olsen KM; DEFINE study group and the Discovery Research Network. A multicenter, prospective, observational study to determine predictive factors for multidrug-resistant pneumonia in critically ill adults: the DEFINE study. Pharmacotherapy 2019;39:253-60.
• Leedahl DD, Personett HA, Nagpal A, Barreto EF. Prevention of Clostridium difficile infection in critically ill adults. Pharmacotherapy 2019;39:399-407.
• Menich B, Miano TA, Patel GP, Hammond DA. Norepinephrine and vasopressin compared to norepinephrine and epinephrine in adults with septic shock. Ann Pharmacother 2019;53:877-85.
• Newsome AS, Bissell BD, Burry LD, Defayete AA, Gagnon DJ, Gilbert BW, Kramer CJ, Miller CJ, Semanco M, Smith MN, Hammond DA. Major publications in critical care pharmacotherapy literature in 2018. J Crit Care 2019;52:200-7.
• Owusu K, Effendi M, Defilippo N, et al. Andexanet alfa: considerations and practical applications. Crit Pathways Cardiol December 2019.
• Sikora Newsome A, Smith SE, Jones TW, et al. A survey of critical care pharmacists to patient ratios and practice characteristics in intensive care units. J Am Coll Clin Pharm 2019 Jul 23. [Epub ahead of print]
• Sikora Newsome A, Smith SE, Olney WJ, Jones TW, Cecil Forehand C, Jun A, et al. Medication regimen complexity is associated with pharmacist interventions and drug-drug interactions: a use of the novel MRC-ICU scoring tool. J Am Coll Clin Pharm 2019 Jun 12. [Epub ahead of print]
• Smith MN, Brotherton AL, Lusardi K, Tan CA, Hammond DA. Systematic review of the clinical utility of methicillin-resistant Staphylococcus aureus (MRSA) nasal screening for MRSA pneumonia. Ann Pharmacother 2019;53:627-38.
• Smith MN, Deloney L, Carter C, Weant K, et al. Safety, efficacy, and cost of four-factor prothrombin complex concentrate (4F-PCC) in patients with factor Xa inhibitor-related bleeding: a retrospective study. J Thromb Thrombolysis 2019;48:250-5.
• Smith SE, Hamblin SE, Dennis BM. Effect of neuromuscular blocking agents on sedation requirements in trauma patients with an open abdomen. Pharmacotherapy 2019;39:271-9.
• Smith SE, Newsome AS, Tackett RL. Prescribing of pressor agents in septic shock: a survey of critical care pharmacists. J Pharm Technol 2019 May 8. [Epub ahead of print]
• Smith ZR, Horng M, Rech MA. Medication-induced hyperlactatemia and lactic acidosis: a systematic review of the literature. Pharmacotherapy 2019 Jul 30. [Epub ahead of print]
• Thompson Bastin ML, Short GT, Rust K, Cook AM, Flannery AH. Perceptions of television-based education in the ICU: a survey comparison among patients and care providers. Am J Crit Care 2019;28:307-15.
• McCleary EJ, Thompson Bastin ML, Bissell BD, Cook AM, Pierce CA, Flannery AH. Development of a co-precepting model for a preceptor-in-training program for new practitioners. Hosp Pharm 2019;54:246-9.

New Fellows

• Jennifer Cole: FCCP – American College of Clinical Pharmacy.
• Joe Dasta: FCCP – American College of Clinical Pharmacy; FCCM – American College of Critical Care Medicine; MCCM – American College of Critical Care Medicine.
• Chris Droege: FCCM – American College of Critical Care Medicine; FASHP – American Society of Health-System Pharmacists.
• Christine Groth: FCCM – American College of Critical Care Medicine.
• Drayton Hammond: FCCM – American College of Critical Care Medicine.
• Jodi Taylor: FASHP – American Society of Health-System Pharmacists.

Other Notable Achievements

• Brittany Bissell: Secretary/Treasurer, ACCP Pulmonary PRN.
• Scott Bolesta: Chair, Research Section, Society of Critical Care Medicine.
• Allison Boyd: BPS Critical Care Standard Setting Panel; Instructor Certification, Advanced Burn Life Support; BCCCP.
• Trisha Brannan: President, Georgia Society of Health-System Pharmacists.
• Michaelia Cucci: Co-chair, Research Forum, Research and Scholarship Committee, Society of Critical Care Medicine, Clinical Pharmacy and Pharmacology Section.
• Joe Dasta: Nominations Committee, Society of Critical Care Medicine.
• Muhammad Effedni: BCCCP; President, New Jersey Health-System Pharmacists Central Chapter.
• Alex Flannery: Secretary/Treasurer, Critical Care PRN; Chair, ACCP Publications Committee; Chair-Elect, SCCM CPP Research and Scholarship Committee.
• Jolie Gallagher: PGY2 Critical Care Residency Director, Emory University Hospital.
• Drayton Hammond: Chair, Education Committee, Society of Critical Care Medicine, Clinical Pharmacy and Pharmacology Section; Co-chair, Mentorship Committee, Society of Critical Care Medicine Research Section; Assistant Professor, Rush Medical College, Department of Internal Medicine – Division of Pulmonary, Critical Care, and Sleep Medicine in the Section of Critical Care Medicine.
• Jahidul Hasan: Expert-lecturer, Pharmacy Council of Bangladesh; Professional recognition/free membership, Healthcare Infection Society, London, UK; Creator and best practitioner of Clinical Drug Investigation System of ADR, Directorate General of Drug Administration, Bangladesh; Established Clinical Pharmacy Services, Square Hospitals Ltd.; Infectious Disease and Critical Care Medicine Clinical Coordinator, Square Hospitals Ltd.; Antibiotics and Resistance, Pasteur Institute, Paris, France.
• Anthony Hawkins: Chair, Student/Resident Committee, Georgia Society of Health-System Pharmacists.
• Mojdeh Heavner: Associate Editor, 3-year term, American Journal of Health-System Pharmacists.
• Judi Jacobi: Retired from IU Health as a Clinician and now a Senior Consultant for Visante, Inc.
• Hasan Kazmi: BCCCP.
• Desiree Kosmisky: Chair, Communications Committee, Carolinas/Virginias Chapter of Society of Critical Care Medicine.
• David Leedahl: BCIDP.
• Richard Lincoln: 2018-19 ACCP Student Chapter President, University of Cincinnati James L. Winkle School of Pharmacy.
• Megan Rech: Member at Large, Society of Critical Care Medicine, Clinical Pharmacy and Pharmacology Section.
• Jodi Taylor: Director-at-Large, Section of Clinical Specialists and Scientists, American Society of Health-System Pharmacists.
• Neesha Thakkar: PGY1 Residency Director, St. David’s Medical Center.
• Toni Vilella: BCCCP, BCPS.

Introduction

The Drug Information (DI) PRN has been providing live and recorded webinars on drug information topics to its members. The PRN’s most recent webinar was presented by Amanda Gerberich, Pharm.D., titled “Adaptive Trial Design.”

The DI PRN also hosts student and resident journal club presentations on a variety of topics. Journal clubs are presented live and recorded. The most recent journal club was presented by Ashley Taylor, Pharm.D., titled “Glucocorticoids in Septic Shock.”

DI PRN leadership will be presenting a poster on the PRN’s history on Saturday, October 26, from 11:00 a.m. to 1:00 p.m. at the ACCP 40th Annual Meeting in New York City. The PRN’s business meeting is scheduled for Monday, October 28, from 6:30 p.m. to 8:30 p.m.

Awards

• Michelle W. McCarthy: American Association of Colleges of Pharmacy (AACP) 2019 Master Preceptor Award.

Publications

• Brown JN, Gordon S, Jacob S, et al. Assessing the economic value of pharmacy resident participation in an investigational drug service. J Pharm Pract 2019 June 23. [Epub ahead of print]
• Brown JN, Tillman F III, Jacob S, et al. Economic outcomes associated with an investigational drug service within a Veterans Affairs health care system. Contemp Clin Trials Commun 2019;14:100354.
• Jacob S, Britt RB, Bryan WE, Hashem MG, Hale JC, Brown JN. Economic outcomes associated with safety interventions by a pharmacist-adjudicated prior authorization consult service. J Manag Care Spec Pharm 2019;25:411-6.
• Shore SN, Britnell SR, Brown JN. Safety analysis of long-term phenazopyridine use for radiation cystitis in a veteran population. J Oncol Pharm Pract 2019 April 22. [Epub ahead of print]
• Kaufman MB, Choy M. Healthcare Heroes: The Medical Careers Guide. In press.
• Thornby K, Thornby R, Torrado C. Practical approaches integrating the topic of drug shortages within the doctor of pharmacy curricula. Am J Pharm Educ 2019;83:264-9.
• Dziewiatkowski N, Osmon E, Chahine EB, Thornby K. Baloxavir: a novel single-dose oral antiviral for the treatment of influenza. Sr Care Pharm 2019;34:243-52.

Presentations

• Thornby K. Incorporating drug shortages using a process oriented guided inquiry learning method in drug information. American Association of Colleges of Pharmacy 2019 Annual Meeting; July 14, 2019; Chicago, IL.
• Thornby K. Join the club! Engaging learners to apply principles of biostatistics and research design to deliver effective journal clubs. Florida Society of Health-System Pharmacists 2019 Annual Meeting; August 2, 2019; Orlando, FL.

Promotions

• Elias Chahine: Professor, Palm Beach Atlantic University, the Lloyd L. Gregory School of Pharmacy.
• Eliza Dy-Boarman: Associate Professor, College of Pharmacy & Health Sciences, Drake University.
• Morgan Herring: Clinical Associate Professor, University of Iowa College of Pharmacy.
• Tsitsi Monera-Penduka: Senior Lecturer, School of Pharmacy, University of Zimbabwe College of Health Sciences.
• Sarah Nisly: Professor, Wingate University School of Pharmacy.
• Lynn Stevenson: Executive Director of Experiential Programs, Auburn University Harrison School of Pharmacy.
• Kali VanLangen: Professor, Ferris State University College of Pharmacy.
• Sarah (Kelling) Vordenberg: Clinical Associate Professor, University of Michigan College of Pharmacy.

Awards

• Paul Boylan: Larkin University College of Pharmacy Class of 2021 Teacher of the Year.
• Elias Chahine: Fellow, Florida Society of Health-System Pharmacists.
• Eliza Dy-Boarman: AACP Emerging Teaching Scholar Award.
• Stephanie Sibicky: 2019 Northeastern University School of Pharmacy Teaching Excellence Award.
• Mate M. Soric: Class of 2019 Most Influential Professor; Class of 2019 Commencement Hooder; Ohio Society of Health-System Pharmacists Pharmacy Practice Research Award.

Grants

• Elias Chahine: Assessing Adherence to the 2017 IDSA/SHEA Clinical Practice Guidelines for Clostridioides difficile Infection After Pharmacy-Led Educational Interventions. Principal investigator. Palm Beach Atlantic University Quality Initiative Grant $1500.

Publications

• Boylan PM, Santibanez M. Upper gastrointestinal bleeding in a male patient taking megestrol acetate and rivaroxaban: a case report. Sr Care Pharm 2019;34:501-9.
• Boylan PM, Sedlacek J, Santibanez M, et al. Development and implementation of interprofessional relations between a college of pharmacy and osteopathic residency programs in a community teaching hospital. J Pharm Technol 2019 Jul 22. [Epub ahead of print]
• Alsharif NZ, Brennan L, Abrons JP, Chahine EB. An introduction to cultural sensitivity and global pharmacy engagement. Am J Pharm Educ 2019;83:7221.
• Alsharif NZ, Khanfar NM, Brennan LF, Chahine EB, et al. Cultural sensitivity and global pharmacy engagement in the Arab world. Am J Pharm Educ 2019;83:7228.
• Alsharif NZ, Khanfar NM, Brennan LF, Chahine EB, et al. Cultural sensitivity and global pharmacy engagement in the United States. Am J Pharm Educ 2019;83:7220.
• Caudle KE, Gammal RS, Karnes JH, Afanasjeva J, Anderson KC, Barreto EF, Beavers C, Bhat S, Birrer KL, Chahine EB, et al. PRN opinion paper: application of precision medicine across pharmacy specialty areas. J Am Coll Clin Pharm 2019;2:288-302.
• Chastain DB, Cluck DB, Stover KR, Lusardi KT, Marx A, Green S, Faulkner-Fennell C, Turner M, Chahine EB, et al. A baker’s dozen of top antimicrobial stewardship intervention publications in 2017. Open Forum Infect Dis 2019;6:ofz133.
• Cluck DB, Bland CM, Chahine EB, et al. A baker’s dozen of top antimicrobial stewardship publications in 2016. JAMS. Preprints 2019, 2019030146.
• Dougherty JA, Sucher AJ, Chahine EB, et al. Omadacycline: a new tetracycline antibiotic. Ann Pharmacother 2019;53:486-500.
• Dziewiatkowski NAS, Osmon ENS, Chahine EB, et al. Baloxavir: a novel single-dose oral antiviral for the treatment of influenza. Sr Care Pharm 2019;34:243-52.
• Hussar DA, Chahine EB. Eravacycline dihydrochloride, plazomicin sulfate, and doravirine. J Am Pharm Assoc 2019;59:293-6.
• Kennedy RA, Padilla ME, Andrews S, Christenberry EJ, et al. Evaluating the standardization of transitions of care in a Texas-Mexico border academic family medicine practice. J Pharm Pract 2019 Jan 22. [Epub ahead of print]
• Reinert JP, Cook EA. Oxcarbazepine-induced cutaneous reaction in a female of Mexican ancestry. J Pharm Technol 2019 May 22. [Epub ahead of print]
• Wooster J, Cook EA, Shipman D. Psychiatric manifestations with sacubitril/valsartan: a case report. J Pharm Pract 2019 Apr 16. [Epub ahead of print]
• Bryant GA, Dy-Boarman EA, Kassel LE. Monitoring adherence to inhaled medications. JAMA 2019;322:692-3.
• Eudaley ST, Dabbs WS, Chamberlin SM. YouTube as a guide for Respimat SoftMist inhaler technique. J Pharm Pract 2019 Jun 23. [Epub ahead of print]
• Eudaley ST, Franks AS. A successful phase II residency match – insights from a program. J Pharm Pract 2019 Apr 9. [Epub ahead of print]
• Eudaley ST, Mihm AE, Higdon R, et al. Development and implementation of a clinical decision support tool for treatment of uncomplicated urinary tract infections in a family medicine resident clinic. J Am Pharm Assoc 2019;59:579-85.
• Isaacs AN, Walton AM, Gonzalvo JD, Howard ML, Nisly SA. Pharmacy educator evaluation of web-based learning. Clin Teach 2019 Feb 11. [Epub ahead of print]
• Law MG, Marriott J, Usifoh C, Muungo FA, Adome RO, Monera-Penduka TG, et al. An analysis of hospital pharmacy practice in six countries of sub-Saharan Africa based on the International Pharmaceutical Federation Basel Statements on the future of hospital pharmacy. Int J Pharm Pract 2019 Jul 1. [Epub ahead of print]
• Nisly SA, Stevens B. Ritonavir or cobicistat-boosted antiretroviral therapy and direct oral anticoagulants: a case for apixaban. Int J STD AIDS 2019;30:718-22.
• Soric MM, Robinson JD, Ulbrich TR. A need for a holistic residency application review process. J Am Coll Clin Pharm 2019;2:321.
• Frost DA, Soric MM, Kaiser R, et al. Efficacy of tramadol for pain management in patients receiving strong cytochrome P450 2D6 inhibitors. Pharmacotherapy 2019;39:724-9.
• Snyder BM, Soric MM. National trends in statin medication prescribing in patients with a history of stroke or transient ischemic attack. J Pharm Pract 2019 Jul 21. [Epub ahead of print]
• Vordenberg SE, Lindell V, Sheerer K, et al. Improving hypertension control through a collaboration between an academic medical center and a chain community pharmacy. J Am Coll Clin Pharm 2019;2:357-65.
• Farhat NM, Vordenberg SE, Marshall VD, et al. Evaluation of interdisciplinary geriatric transitions of care on readmission rates. Am J Manag Care 2019;25:e219-e223.
• Yang T, Ruegger M, Colavecchia AC, et al. Comparison of levothyroxine dosing in patients with and without heart failure. Endocr Res 2019:1-8.

New ACCP Fellows

• Mate M. Soric

Other Notable Achievements

• Stephanie Sibicky: Master’s of Education in eLearning and Instructional Design.

Introduction

Members of the EMED PRN have been involved in several prestigious awards and publications. The PRN has continued to host journal club webinars from pharmacy residents and students across the country. The monthly journal clubs have grown to two presenters each month, and attendance has continued to increase. In addition, the Twitter account has stayed active with daily tweets and has achieved over 2195 followers.

Promotions

• Christi Cumba Jen:Clinical Pharmacy Manager at Honor Health Deer Valley Medical Center (August 2019).

Awards

• Tuqa Alkhateeb: First place in Doctoral Medicine & Disease Oral Presentations at the 2019 Appalachian Student Research Forum.
• Heather Blue: University of Minnesota: Teacher of the Year (PD3 2020), Duluth PD3 class; Professor of the Class (2019), University of Minnesota College of Pharmacy; Outstanding Pharmacist Award (2019) Minnesota Society of Health-System Pharmacists.
• Christi Cumba Jen: Preceptor of the Year for Midwestern University College of Pharmacy – Glendale (May 2019).

Grants

• Craig Cocchio: Amphastar Pharmaceuticals Inc. Research Grant ($3200). Retrospective Study on Safety of Dosing Volume Greater than or Equal to 0.25mL of Intranasal (IN) Medications in Children (0–3 Years of Age). Role: principal investigator.

Publications

• Alkhateeb T, Kumbhare A, Bah I, et al. S100A9 maintains myeloid-derived suppressor cells in chronic sepsis by inducing miR-21 and miR-181b. Mol Immunol 2019;112:72-81.
• Blue H, Hawthorne AN, Melgaard K, et al. Pharmacist involvement combating the opioid crisis: a mixed-methods approach revealing unrealized potential. J Am Coll Clin Pharm 2019 May 8. [Epub ahead of print]
• Palombi L, Hawthorne AN, Lunos S, Melgaard K, Dahly A, Blue H. Community pharmacist utilization of legislation that allows impact on the opioid crisis in the state of Minnesota: a mixed-methods approach. J Pharm Pract 2019 Apr 14. [Epub ahead of print]
• Burkins J, DeMott JM, Slocum GW, et al. Factors associated with unsuccessful follow-up in patients undertreated for gonorrhea and chlamydia infections. Am J Emerg Med 2019 Jun 4. [Epub ahead of print]
• Cocchio C. Top 50 OTC drug. In: Busti A, ed. High-Yield MED Reviews.
• Cocchio C. Top 40 antidotes in toxicology. In: Busti A, ed. High-Yield MED Reviews.
• Overberg A, Morton S, Wagner E, et al. Toxicity of bupropion overdose compared with selective serotonin reuptake inhibitors. Pediatrics 2019;144(2).
• Khobrani M, Perona S, Patanwala AE. Effect of a legislative mandate on opioid prescribing for back pain in the emergency department. Am J Emerg Med 2019 Feb 22. [Epub ahead of print]
• Rech MA, Mosier MJ, Zelisko S, et al. Outcomes in burn-injured patients who develop sepsis. J Burn Care Res 2019 Feb 26. [Epub ahead of print]
• Garg R, Rech MA, Schneck M. Stroke mimics: an important source of bias in acute ischemic stroke research. J Stroke Cerebrovasc Dis 2019 Jun 28. [Epub ahead of print]
• Hammond DA, Flowers HJC, Meena N, Painter JT, Rech MA. Cost avoidance associated with clinical pharmacist presence in a medical intensive care unit. J Am Coll Clin Pharm 2019:1-6.
• Hammond DA, Gurnani PK, Flannery AH, Smetana KS, Westrick JC, Lat I, Rech MA. Scoping review of interventions associated with cost avoidance able to be performed in the intensive care unit and emergency department. Pharmacotherapy 2019;39:215-31.
• Hammond DA, Lam SW, Rech MA, et al. Balanced crystalloids versus saline in critically ill adults: a systematic review and meta-analysis. Ann Pharmacother 2019 Jul 31. [Epub ahead of print]
• Hammond DA, McCreary EK, Rech MA, et al. Perceptions and practices for beta-lactam antibiotic dosing, administration, and monitoring in critically ill patients: current views and use among critical care and infectious diseases pharmacists. J Am Coll Clin Pharm 2019;1-9.
• Hammond DA, Rech MA. How-to guide for effectively performing and coordinating multicenter observational research as a clinical pharmacist. J Am Coll Clin Pharm 2019 Jul 30. [Epub ahead of print]
• Hammond DA, Rech MA, Daley MJ, et al. Pharmacist perceptions regarding vasopressin use in septic shock and cost containment strategies. J Am Coll Clin Pharm 2019;2:257-67.
• Hammond DA, Trivedi A, Esmero VM, Hamadeh L, Heikkinen B, Tan C, Hanson A, Rech MA. Pharmacists’ perceptions and practice changes resulting from emergence of the vancomycin-piperacillin/tazobactam nephrotoxicity phenomenon. J Am Coll Clin Pharm 2019 Jul 25. [Epub ahead of print]
• Masic D, Colon Hidalgo D, Kuhrau S, Chaney W, Rech MA. Pharmacist presence decreases time to prothrombin complex concentrate in emergency department patients with life-threatening bleeding and urgent procedures. J Emerg Med 2019 Aug 22. [Epub ahead of print]
• Smith ZR, Horng M, Rech MA. Medication-induced hyperlactatemia and lactic acidosis: a systematic review of the literature. Pharmacotherapy 2019 Jul 30. [Epub ahead of print]
• Zavala S, Larson J, O’Mahony M, Rech MA. Impact of insufficient admission vitamin D serum concentrations on sepsis incidence and clinical outcomes in patients with thermal injury. Burns. In press.

Other Notable Achievements

• Craig Cocchio: ASHP Accreditation – Emergency Medicine PGY2, CHRISTUS Trinity Mother Frances Health System, Tyler, Texas.
• Lynn Lamkin: ASHP Accreditation – Emergency Medicine PGY2, University of Louisville Hospital, Louisville, Kentucky.

The Endocrine and Metabolism PRN is composed of pharmacists and student pharmacists from a variety of practice settings. The PRN was formed to achieve the following goals and objectives. (1) Provide an opportunity for pharmacists with an interest in endocrine and metabolism disorders to promote practice, research, and education in these areas. (2) Provide a mechanism for members with similar interests to meet during ACCP meetings to network, problem solve, and discuss professional issues and opportunities. (3) Promote practice involvement; educational needs of health care professionals, students, and patients; and research activities in the areas of endocrinology and metabolism that might be favorably affected by this ACCP PRN effort. The most recent PRN blog is available at https://endoprn.wordpress.com/2019/08/15/sglt-2-inhibitors-the-new-kids-on-the-block-for-management-of-diabetic-nephropathy . During the past 6 months, notable member accomplishments include the following.

Promotions

• Justinne Guyton: Associate Professor at St. Louis College of Pharmacy.
• Nathan Painter: Clinical Professor, University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences.

Awards

• Diana Isaacs: AADE Diabetes Educator of the Year Award and the Ohio Pharmacists Association Under 40 Award.
• John Mooreman: P3 Teacher of the Year and P4 Core Faculty Preceptor of the Year for Northeast Ohio Medical University College of Pharmacy.
• Sara (Mandy) Reece: PCOM Georgia SOP Department of Pharmacy Practice Teacher of the Year.
• Heather Whitley: Mahlon Turner Pharmacy Fellow in Outreach for Auburn University Harrison School of Pharmacy, Certificate of Appreciation for Webinar presentation for APhA-APPM Diabetes Management SIG and Outstanding Contributions Award for APhA-APPM Diabetes Management SIG.

Grants

• Dixon DL. Developing and Implementing Interprofessional Strategies to Improve Diabetes and Cardiovascular Disease Prevention and Management in Underserved Areas. Virginia Department of Health (CDC-RFA-DP18-1815). Funded 2019–2024 ($1,262,290). Role: principal investigator.
• Gupta V, Begley K, Curtis S, Tran D, Woodyard J. Assessment of Drug Utilization Review Evaluation Tools in Schools and Colleges of Pharmacy. American Association of Colleges of Pharmacy Laboratory Instructors SIG $350.00. Role: principal investigator. January 2019.
• Gupta V, Williams E. A Qualitative Analysis of Residency Program Directors’ Understanding of Development of Depressive Symptoms in Pharmacy Residents. Roseman University Intramural Grant $7500. Role: principal investigator. February 2019.

Publications

• Al-Omar LT, Anderson SL, Cizmic AD, et al. Evaluation of the implementation of a pharmacist-led diabetes management protocol. Am Health Drug Benefits 2019;12:14-20.
• Courtney L, Anderson SL, Marrs JC. Lipid lowering therapy for primary prevention in the HIV patient. LipidSpin 2019;17(2).
• Reinert JP, Cook EA. Oxcarbazepine-induced cutaneous reaction in a female of Mexican ancestry. J Pharm Technol 2019 May 22. [Epub ahead of print]
• Wooster J, Cook EA, Shipman D. Psychiatric manifestations with sacubitril/valsartan: a case report. J Pharm Pract 2019 Apr 16. [Epub ahead of print]
• Bonaventura A, Carbone S, Dixon DL, et al. Pharmacologic strategies to reduce cardiovascular disease in type 2 diabetes mellitus: focus on SGLT2-inhibitors and GLP-1 receptor agonists. J Intern Med 2019;286:16-31.
• Carbone S, Dixon DL. The CANVAS program: implications of canagliflozin on reducing cardiovascular risk in patients with type 2 diabetes mellitus. Cardiovasc Diabetol 2019;18:1-13.
• French EK, Donihi AC, Korytkowski MT. Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients. BMJ 2019;365:1114.
• Hsu A, Painter NA. Probable interaction between warfarin and inhaled and oral administration of cannabis. J Pharm Pract 2019 Jul 18. [Epub ahead of print]
• Schumacher C, Van Dril E. Clinical pharmacist’s role in heart failure management and the expansion of clinical pharmacist services in health care reform. In: Castelli G, ed. ACCP Ambulatory Care Pharmacist’s Survival Guide, 4th ed. Lenexa, KS: American College of Clinical Pharmacy, 2019:125-37.
• Van Dril E, Schumacher C. Impact of professional continuous glucose monitoring by clinical pharmacists in an ambulatory care setting. J Am Coll Clin Pharm 2019;1-7.
• Whitley HP, Hanson C, Parton JM, et al. Rationale of family medicine physicians in effectively identifying patients with chronic hyperglycemia through point-of-care hemoglobin A1C screenings. J Diabetes Metab Disord 2019;402:1-8.
• Whitley HP, Lee R, Steil C, et al. Student pharmacists’ service-oriented learning at a camp for children with type 1 diabetes mellitus. Curr Pharm Teach Learn 2019;11:825-31.
• Whitley HP, Smith WD. Sex-based difference in medications for heart failure. Lancet 2019 Aug 22. [Epub ahead of print]
• Gamston CE, Kirby AN, Hansen RA, Redden DT, Whitley HP, et al. Description of a pharmacist-led diabetes prevention service within an employer-based wellness program. J Am Pharm Assoc 2019;59:736-41.

Presentations

• Isaacs D:

  The ins and outs of starting a CGM program. Presented as an online webinar for: American Association of Diabetes Educators; June 2019.

  CGM data in clinical practice. Presented as an online webinar for: American Association of Diabetes Educators; June 2019.

• Moorman JM:

  A class effect or not? An update on the adverse event literature associated with sodium-glucose co-transporter 2 inhibitors. Ohio Society of Health-System Pharmacists Annual Meeting; May 2019; Columbus, OH.

  Utilization of high-intensity statins in ambulatory patients at risk for atherosclerotic cardiovascular disease events: a national cross-sectional study. Ohio Pharmacists Association Annual Conference and Trade Show; April 2019; Columbus, OH.

• Schumacher C: Guidelines for non-insulin medication management in patients with type 2 diabetes. Presented as a live webinar for: American Association of Diabetes Educators; April 2019.
• Simmons K, Covington L: Providing diabetes care in the uninsured and underinsured population. Texas Society of Health-System Pharmacists Annual Meeting; April 2019; Frisco, TX.
• Turco N: Subclinical hypothyroidism: to treat or not to treat? ASHP Summer Meeting; June 2019; Boston, MA.

Poster Presentations

• Leon B, Oronce CI, Marrs JC, Anderson SL, Vlasimsky TB, Richesin SD, Valdez CA, Hanratty R. Characterizing high-risk atrial fibrillation patients in a safety net institution to identify trends that may help improve anticoagulation guideline adherence and stroke prevention. Annual Meeting of the Society of General Internal Medicine; May 2019; Washington, DC.
• Isaacs D, Zimmerman R, Lansang MC. Impact of comprehensive medication therapy management in an endocrinology clinic. American Diabetes Association; June 2019; San Francisco, CA.
• Blanchette J, Isaacs D, Noe D, Galloway N, Ha A. The impact of CGM monitoring shared medical appointments on planned diabetes self-management changes. American Diabetes Association; June 2019; San Francisco, CA.

New ACCP Fellows

• Christie Schumacher

Other Notable Achievements

• Nicole Slater: Selected for the Alabama Leadership Initiative.

Presentations

• Marty Eng: Alzheimer’s update. 2019 Drug-Smith Continuing Education and Trade Show.
• Lisa Hutchison: What’s new with old drugs? 2019 American Geriatrics Society Annual Meeting; May 4, 2019; Portland, OR.
• Lisa Hutchison: “Principles of Aging” and “Complex Case: Inpatient Surgery to Skilled Nursing Facility” for the 2019 ASHP/ACCP Geriatric Pharmacy Specialty Review and Recertification Course; May 2, 2019; Minneapolis, MN.

Publications

Books

• Michele B. Kaufman and Mary Choy: Healthcare Heroes: The Medical Careers Guide.

Articles

• Lerchenfeldt S, Mi M, Eng M. The utilization of peer feedback during collaborative learning in undergraduate medical education: a systematic review. BMC Med Educ 2019;19:Article number 321.

Grants

• Julianna Fernandez, Nancy Ordonez, Catherine Hatfield. Southeast Texas Geriatrics Workforce Enhancement Grant (SETx-GWEP). Role in grants: principal investigator: Brian Reed. Funding agency: Health Resources & Services Administration. Funding: $396,702 (1 of 7 subawards). Duration of funding: 5 years (July 2019 – June 2024).

New ACCP Fellows

• Crystal Burkhardt

Promotions

• Marty Eng: Cedarville University – Full Professor.

Other Notable Achievements

• Emily Peron: Appointed to the Parkinson’s Foundation Aware in Care Advisory Committee in July 2019.
• Stephanie Sibicky: Received Master’s of Education from Northeastern University in June 2019.

Promotions

• Branden Nemecek: Associate Professor, Duquesne University Mylan School of Pharmacy.
• Emmanuel Saltiel: Clinical Pharmacist, Gastroenterology, Inflammatory Bowel Program and Small Bowel Disease & Nutrition Program, Cedars-Sinai Medical Center.

Grants

• Michelle T. Martin, Rodrigo M. Burgos, Renata O. Smith. Cohort Study of Hepatitis C Virus Treatment with Zepatier (elbasvir/grazoprevir) in Genotype 1 or 4 HCV Treatment-Naive or Peginterferon/ribavirin-Experienced Patients with Substance Use in Urban, Multidisciplinary Specialty Clinics. Investigator-sponsored research. Funded by: Merck. Sarah M. Michienzi (principal investigator).

Publications

• Martin MT. Gastrointestinal disorders. In: Bainbridge JL, Cardone K, Cross LB, et al. ACCP/ASHP 2019 Ambulatory Care Pharmacy Preparatory Review and Recertification Course. Lenexa, KS: American College of Clinical Pharmacy, 2019:983-1091.
• Martin MT. HCV screening: how can pharmacists get involved? Clin Care Options Online. May 21, 2019.
• Martin MT. Hepatitis C virus management in the post-pipeline era. In: Dixon DL, Harris IM, eds. Ambulatory Care Self-Assessment Program, 2019 Book 2. Infection Primary Care. Lenexa, KS: American College of Clinical Pharmacy, 2019:7-28.
• Koren D, Zuckerman A, Teply R, Nabulsi N, Lee T, Martin MT. Expanding hepatitis C virus care and cure: national experience using a clinical pharmacist-driven model. Open Forum Infect Dis 2019;6:ofz316.
• Michienzi SM, Martin MT. Hepatitis A, B, and D. In: Dodds Ashley ES, Gross AE, eds. Infectious Diseases Self-Assessment Program, 2019 Book 1. HIV and Hepatitis. Lenexa, KS: American College of Clinical Pharmacy, 2019:85-104.

Other Notable Achievements

• Britta Staubes: Residency Program Director for the PGY2 Pharmacotherapy Residency Program at Ochsner Medical Center.

Presentations

• Sally A. Arif: Global burden of heart disease & diabetes and the interprofessional team. International Symposium hosted by RAK Medical & Sciences University; United Arab Emirates.
• Katelyn R. Dervay: Pharmaceutical interventions in the trauma bay: more than analgesics. Florida Society of Health-System Pharmacists Annual Meeting; August 2, 2019.
• Melanie Nicol:

  Chesdachai S, Rajasingham R, Nicol MR, Meya D, Bongomin F, Abassi M, Skipper C, Kwizera R, Rhein J, Boulware DR. Minimum inhibitory concentration distribution of fluconazole against Cryptococcus species and the fluconazole exposure prediction model. ID Week; October 2019; Washington, DC.

  Eneh PC, Hullsiek KH, Kiiza D, Rhein JR, Meya DB, Boulware DR, Nicol MR. Prevalence and nature of potential drug-drug interactions among HIV patients in a large inpatient cohort in Uganda. International Aids Society Conference; July 2019; Mexico City.

  Nicol MR, Eneh P, Nakalega R, Kabwigu S, Isingel E, Kiwanuka N, Beksinska M, Sykes C, Fowler MG, Brown TT, Matovu FK. Depo-medroxyprogesterone effects on tenofovir-dp and lamivudine-tp in cervical tissue. Poster presented at: Conference on Retroviruses and Opportunistic Infections 2019; March 2019; Seattle, WA.

  Nicol MR, Kaiser T, Corbino JA, Kabwigu S, Isingel E, Staley C, Matovu FK. Vaginal microbiome is associated with tenofovir diphosphate and lamivudine triphosphate in cervical tissues of Ugandan women. International Workshop on HIV and Women; March 2019; Seattle, WA.

Awards

• Sally A. Arif: 2019 Teacher of the Year at Midwestern University, Chicago College of Pharmacy.
• Katelyn R. Dervay: Faculty for ASHP Emergency Medicine Certificate.
• Emily Peron: Outstanding University-Community Partnership by the VCU Council for Community Engagement Award to the Humanitarian Outreach Medical Brigade Relief Effort (HOMBRE) – led by Dr. Peron.
• Gina M. Prescott:

  Prescott GM, Bosso NA, Mullen T, Miller ML, Berlie H, Sawyer J. Pre- and post-travel health recommendations for Pharm.D. students engaged in global health experiences. Am J Pharm Educ 2019;83:Article 7654. Poster presented at: 120th Annual Meeting of the American Association of Colleges of Pharmacy; July 2019; Chicago, IL.

  Prescott GM, Sawyer J, Prescott WA Jr, Reiman AT, Morse E. Competency-driven global outreach experiences. Am J Pharm Educ 2019:83:Article 7626. Poster presented at: 120th Annual Meeting of the American Association of Colleges of Pharmacy; July 2019; Chicago, IL.

• Autumn Zuckerman:

  Innovative Pharmacy of the Year, Tennessee Pharmacists Association, June 2019.

  Chelewski R, Johnson K, Zuckerman A, Peter M, DeClercq J, Choi L, Langone A. Development of a pharmacy collaborative practice agreement to improve efficiency and management of prescribing in a renal transplant clinic. Presented at: Academy of Managed Care and Specialty Pharmacy Annual Meeting; March 2019; San Diego, CA.

  Cherry E, Jolly J, Zuckerman A, Peter M. Adherence to specialty medications: assessing rates and correlates of nonadherence at an integrated specialty pharmacy. Presented at: Academy of Managed Care and Specialty Pharmacy Annual Meeting; March 2019; San Diego, CA.

  Crothers G, Shah N, Kim M, Zuckerman A. Development of a quality measures tool for the utilization of tyrosine kinase inhibitors in non–small cell lung cancer: an integrated specialty pharmacy initiative. Poster presented at: Pharmacy Quality Alliance Annual Meeting; May 2019; Baltimore, MD.

  Haydek J, Shah N, Zuckerman A, Wong R, Garret A, Duley C, Annis K, Wagnon J, Dalal R, Scovile E, Beaulieu D, Schwartz D, Slaughter C, Horst S. Non-adherence to self-injectable biologic medication in patients with moderate to severe inflammatory bowel disease is associated with increased healthcare resource utilization. Presented at: Digestive Disease Week 2019; May 2019; San Diego, CA.

  Livezey S, McCormick R, Shah N, Choi L, DeClercq J, Zuckerman A. Impact of specialty pharmacist integration on time to medication access for pimavanserin. Presented at: College of Psychiatric and Neurologic Pharmacists Annual Meeting; April 2019; Salt Lake City, UT.

  Nabulsi NA, Martin MT, Sharp LK, Koren DE, Teply R, Zuckerman A, Lee TA. Prediction model of treatment failure among chronic HCV. Poster presented at: ISPOR 2019; May 2019; New Orleans, LA.

  Nix R, Looney B, Lamb C, Peter M, Zuckerman A. A targeted approach to reducing rates of discontinuation and dose reduction in patients receiving sorafenib or regorafenib. Presented at: Academy of Managed Care and Specialty Pharmacy Annual Meeting; March 2019. San Diego, CA.

Publications

• Ellis J, Eneh PC, Ssebambulidde K, Rutakingirwa MK, Lamorde M, Rhein J, Cresswell FV, Boulware DR, Nicol MR. Three’s a crowd: diagnostic and pharmacokinetic challenges in HIV-TB meningitis-malaria co-infection. A case report. Wellcome Open Res 2019;3:111.
• Nicol MR, Eneh PC, Nakalega R, et al. Depot medroxyprogesterone acetate and the vaginal microbiome as modifiers of tenofovir diphosphate and lamivudine triphosphate concentrations in the female genital tract of Ugandan women: implications for TDF/3TC in pre-exposure prophylaxis. Clin Infect Dis 2019 May 25. [Epub ahead of print]
• Nicol MR, Taylor J, Pastick K, et al. Cerebrospinal fluid and brain tissue penetration of tenofovir, lamivudine, and efavirenz in post-mortem tissues with cryptococcal meningitis. Clin Transl Sci 2019 Jun 17. [Epub ahead of print]
• Chesdachai S, Rajasingham R, Nicol MR, et al. Minimum inhibitory concentration distribution of fluconazole against Cryptococcus species and the fluconazole exposure prediction model. Open Forum Infect Dis 2019 Aug 17. [Epub ahead of print]
• Rhein J, Hullsiek KH, Tugume L, Nuwagira E, Mpoza E, Evans EE, Kiggundu R, Pastick KA, Ssebambulidde K, Akampurira A, Williams DA, Bangdiwala A, Abassi M, Musubire A, Nicol MR, et al; on behalf of the ASTRO-CM study team. Adjunctive sertraline in HIV-associated cryptococcal meningitis: a randomized, placebo-controlled, double-blind phase 3 trial. Lancet Infect Dis 2019;19:843-51.
• Banks A, Peter M, Holder G, Jolly J, Markley B, Zuckerman S, Choi L, Nwosu S, Zuckerman A. Adherence to disease modifying therapies at a multiple sclerosis clinic: the role of the specialty pharmacist. J Pharm Pract 2019 Jan 30. [Epub ahead of print]
• Koren D, Zuckerman A, Teply R, et al. Expanding hepatitis C virus care and cure: national experience using a clinical pharmacist-driven model. Open Forum Infect Dis 2019;6:ofz316.
• Paolella D, Cherry E, Jolly J, DeClercq J, Choi L, Zuckerman A. Closing the gap: identifying rates and reasons for nonadherence in a specialty population. J Manage Care Spec Pharm 2019.
• Reynolds V, Chinn M, Jolly J, Kelley T, Peter M, Choi L, Nwosu S, Carranza Leon B, Zuckerman A. Integrated specialty pharmacy yields high PCSK9 inhibitor access and initiation rates. J Clin Lipid 2019;13:254-64.
• Shah NB, Jolly JA, Horst SN, Peter M, Limper H, Zuckerman AD. Development of a quality measures tool for the use of self-injectable biologic therapy in inflammatory bowel disease: an integrated specialty pharmacy initiative. Am J Health Syst Pharm 2019;76:1296-304.
• Shah NB, Mitchell RE, Proctor ST, Choi L, DeClercq J, Jolly JA, Hemnes AR, Zuckerman AD. High rates of medication adherence in patients with pulmonary arterial hypertension: an integrated specialty pharmacy approach. PLoS One 2019;14:e0217798.

Promotions

• Adriane Irwin: Associate Professor (Clinical), Oregon State University/Oregon Health & Science University College of Pharmacy.

Awards

• Erin Weeda: Overall Teacher of the Year, MUSC College of Pharmacy; P3 Teacher of the Year, MUSC College of Pharmacy; Outstanding Mentor of the Year, MUSC College of Pharmacy.

Publications

• Irwin AN, Stewart OC, Nguyen VQ, et al. Public perception of pharmacist-prescribed self-administered non-emergency hormonal contraception: an analysis of social media comments. Res Social Adm Pharm 2019;15:650-5.
• Hartung DM, Johnston K, Irwin AN, et al. Trends in coverage for disease-modifying therapies for multiple sclerosis in Medicare Part D. Health Aff (Millwood). 2019;38:303-12.
• Walsh S, Irwin AN, Anderson L, et al. Development of a pharmacist-provided contraceptive service following passage of Oregon House Bill 2879. J Am Pharm Assoc (2003). 2019;59(4 suppl):S112-6.
• Weeda ER, Casserly C, Britton D, et al. Loop diuretic use among patients with heart failure and type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors. J Diabetes Complications 2019;33:567-71.
• Weeda ER, Weant KA. Development of a pharmacy residency research certificate program. Hosp Pharm 2019 Aug 2. [Epub ahead of print]
• Claudio AM, Foltanski L, Delay T, Britell A, Duckett A, Weeda ER, Bohm N. Antibiotic use and respiratory pathogens in adults with sickle cell disease and acute chest syndrome. Ann Pharmacother 2019;53:991-6.
• Keeney KP, Calhoun C, Jennings L, Weeda ER, Weant KA. Assessment of intravenous insulin dosing strategies for the treatment of acute hyperkalemia in the emergency department. Am J Emerg Med 2019 Jul 26:158374. [Epub ahead of print]

Introduction

The Hematology/Oncology PRN continues to provide a forum for hematology/oncology pharmacists to network and collaborate on scientific, educational, and political issues affecting clinical practice, teaching, and research. The PRN has 721 members, with trainees (students and residents) making up almost 50% of the membership.

At the 2018 Annual Meeting, the PRN hosted resident and student travel awardees. With a continued increase in student membership and engagement as well as the desire for more opportunities to connect, the second half of the PRN meeting served as a networking session focused on clinical and research activities of the membership. A highlight of the meeting last year was a research presentation given by one of the PRN’s student members and travel award recipient. One of the PRN’s requests was to increase the involvement of students and residents; therefore, the PRN has activities geared toward trainees. Members also formed three committees within the PRN, which include trainees, to help the PRN officers complete their initiatives, which, over the past year, have included establishing a regular newsletter highlighting member accomplishments, clinical updates, and other topics.

The PRN plans to donate to the Frontiers Fund, and nominations for 2019 awards have been submitted. Plans for PRN collaboration with the Pharmaceutical Industry PRN are under way for the 2019 PRN focus session.

Promotions

• R.D. Harvey: Professor of Hematology and Medical Oncology and Pharmacology and Medical Oncology, Emory University School of Medicine; Chair of ASCO Cancer Research Committee 2019–2020.

Awards

• A. Glode: Hematology/Oncology Pharmacy Association Patient Advocacy Award; 40 Under 40 in Cancer Award, supported by supported by The Lynx Group, McGivney Global Advisors, Upstream Partners, and Swim Across America.

Publications

• Adele N. Current treatment landscape and emerging therapies for pancreatic cancer. Am J Manag Care 2019;25(1 suppl):S3-S10.
• Hill H, Arnall J, Janes A, et al. A review of R-DHAP in the outpatient setting and a case of the alternative regimen R-DHAX given outpatient for refractory diffuse large B-cell lymphoma. J Oncol Pharm Pract 2019 Jan 7. [Epub ahead of print]
• Pillinger KE, McClanahan S, Arnall J, et al. Expanding beyond vancomycin and aminoglycosides: a novel foscarnet pharmacist-managed dosing service. Ann Pharmacother 2019;53:1069-70. [Epub ahead of print]
• Arnall JR, Moore DC, Hill HL, Griffin S, Mueller MK, Lavery LA, Voorhees PM, Usmani SZ. Enhancing the feasibility of outpatient daratumumab administration via a split-dosing strategy with initial doses. Leuk Lymphoma 2019 Mar 8. [Epub ahead of print]
• Hartsell L, Janes A, Larck C, Park S, Arnall JR. Ibrutinib for the treatment of Bing-Neel syndrome, a complication of Waldenstrom macroglobulinemia: patient case report. J Oncol Pharm Pract 2019;25:1534-9.
• Zhao JC, Arnall JR, Martin AL, Atrash S, Bhutani M, Voorhees P, Avalos B, Copelan E, Ghosh N, Hamadani M, Usmani, Ford P. A review of growth factor support in bloodless autologous hematopoietic stem-cell transplant. Biol Blood Marrow Transplant 2019 Jul 8. [Epub ahead of print]
• Barreto JN, Cullen MW, Mara KC, et al. QT prolongation in patients with acute leukemia or high-risk myelodysplastic syndrome prescribed antifungal prophylaxis during chemotherapy-induced neutropenia. Leuk Lymphoma 2019 Jul 12. [Epub ahead of print]
• Aitken SL, Nagel JL, Abbo L, Alegria W, Barreto JN, et al.; Antimicrobial Stewardship in Cancer Consortium ASCC. Antimicrobial stewardship in cancer patients: the time is now. J Natl Compr Canc Netw 2019;17:772-5.
• Daniels LM, Durani U, Barreto JN, et al. Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropenia. Support Care Cancer 2019 Feb 25. [Epub ahead of print]
• Ritchie BM, Barreto JN, Barreto EF, et al. Relationship of ganciclovir therapeutic drug monitoring with clinical efficacy and patient safety. Antimicrob Agents Chemother 2019;63(3).
• Wieruszewski PM, Barreto EF, Barreto JN, et al. Preadmission corticosteroid therapy and the risk of respiratory failure in adults without HIV presenting with Pneumocystis pneumonia. J Intensive Care Med 2019 Feb 27. [Epub ahead of print]
• Kuhn AK, Bartoo GT, Dierkhising RA, et al. Iron deficiency anemia associated with extracorporeal photopheresis: a retrospective analysis. J Clin Apher 2019 Aug 22. [Epub ahead of print]
• Anderson SM, Beck B, Sterud S, et al. Evaluating the use of appropriate anticoagulation with lenalidomide and pomalidomide in patients with multiple myeloma. J Oncol Pharm Pract 2019;25:806-12.
• Potter A, Beck B, Ngorsuraches S. Tbo-filgrastim versus filgrastim for stem cell mobilization and engraftment in autologous hematopoietic stem cell transplant patients: a retrospective review. J Oncol Pharm Pract 2019 Mar 9. [Epub ahead of print]
• Beechinor RJ, Cohen-Wolkowiez M, Jasion T, et al. A dried blood spot analysis for solithromycin in adolescents, children, and infants: a short communication. Ther Drug Monit 2019 Jul 15. [Epub ahead of print]
• Beechinor RJ, Thompson PA, Hwang MF, et al. The population pharmacokinetics of high-dose methotrexate in infants with acute lymphoblastic leukemia highlight the need for bedside individualized dose adjustment: a report from the Children’s Oncology Group. Clin Pharmacokinet 2019;58:899-910.
• Dressler LG, Bell GC, Abernathy PM, et al. Implementing pharmacogenetic testing in rural primary care practices: a pilot feasibility study. Pharmacogenomics 2019;20:433-46.
• Dressler LG, Bell GC, Schuetze DP, et al. Implementing a personalized medicine cancer program in a community cancer system. Pers Med 2019;16:221-32.
• Chung C, Kim S, Bubalo J. Instilling value, quality, and safety through hematology and oncology stewardship. Am J Health Syst Pharm 2019;76:617-21.
• Offin M, Guo R, Wu SL, Sabari J, Land JD, Ni A, Montecalvo J, Halpenny DF, Buie LW, et al. Immunophenotype and response to immunotherapy of RET-rearranged lung cancers. JCO Precis Oncol 2019 May 16. [Epub ahead of print]
• Dorajoo SR, Winata CL, Goh JHF, Ooi ST, Somani J, Yeoh LY, Lee SY, Yap CW, Chan A, et al. Optimizing vancomycin dosing in chronic kidney disease by deriving and implementing a web-based tool using a population pharmacokinetics analysis. Front Pharmacol 2019;10:641.
• Ong AM, Fong WW, Chan AK, et al. Using the postgraduate hospital educational environment measure to identify areas for improvement in a Singaporean residency program. J Grad Med Educ 2019;11(4 suppl):73-8.
• Asquith CRM, Maffuid KA, Laitinen T, Torrice C, Tizzard GJ, Crona DJ, et al. Targeting an EGFR water network using novel 4-anilinoquin(az)olines inhibitors for chordoma. ChemMedChem 2019 Aug 19. [Epub ahead of print]
• Babiker HM, Davis L, Larson K, et al. A multidisciplinary evaluation of barriers to enrolling cancer patients into early phase clinical trials: challenges and patient-centric recommendations. Expert Opin Investig Drugs 2019;28:675-86.
• Davis LE, Nicholls LA, Babiker HM, et al. PD-1 inhibition achieves a complete metabolic response in a patient with malignant peripheral nerve sheath tumor. Cancer Immunol Res 2019 Aug 5. [Epub ahead of print]
• Haas NB, Appleman LJ, Stein M, Redlinger M, Wilks M, Xu X, Onorati A, Kalavacharla A, Kim T, Zhen CJ, Kadri S, Segal JP, Gimotty PA, Davis LE, et al. Autophagy inhibition to augment mTOR inhibition: a phase I/II trial of everolimus and hydroxychloroquine in patients with previously treated renal cell carcinoma. Clin Cancer Res 2019;25:2080-7.
• Stitzlein LM, Stang CRT, Inbody LR, Rao PSS, Schneider RA, Dudley RW. Design, synthesis, and biological evaluation of lipophilically modified bisphenol Z derivatives. Chem Biol Drug Des 2019;94:1574-9.
• Hughes JA, Cleven AJ, Ross J, Fuentes DG, Elbarbry F, Suzuki M, Della Paolera M, Carter NS, Stamper B, Low P, Malhotra A, Faro SJE. A comprehensive reflective journal-writing framework for pharmacy students to increase self-awareness and develop actionable goals. Am J Pharm Educ 2019;83:6554.
• Wang E, Jan AS, Doan VP, Ferguson JB, et al. Leflunomide therapy for refractory cytomegalovirus infections in hematopoietic stem cell transplant recipients. J Oncol Pharm Pract 2019;25:1731-7.
• Conlon KC, Potter EL, Pittaluga S, Lee CR, Miljkovic MD, Fleisher TA, Dubois S, Bryant BR, Petrus M, Perera LP, Hsu J, Figg WD, et al. IL15 by continuous intravenous infusion to adult patients with solid tumors in a phase I trial induced dramatic NK-cell subset expansion. Clin Cancer Res 2019;25:4945-54.
• Floudas CS, Brar G, Mabry-Hrones D, Duffy AG, Wood B, Levy E, Krishnasamy V, Fioravanti S, Bonilla CM, Walker M, Morelli MP, Kleiner DE, Steinberg SM, Figg WD, et al. A pilot study of the PD-1 targeting agent AMP-224 used with low-dose cyclophosphamide and stereotactic body radiation therapy in patients with metastatic colorectal cancer. Clin Colorectal Cancer 2019 Jul 2. [Epub ahead of print]
• Komiya T, Memmott RM, Blumenthal GM, Bernstein W, Ballas MS, De Chowdhury R, Chun G, Peer CJ, Figg WD, et al. A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non–small cell lung cancer. Transl Lung Cancer Res 2019;8:247-57.
• Kurmasheva RT, Bandyopadhyay A, Favours E, Del Pozo V, Ghilu S, Phelps DA, Erickson SW, Peer CJ, Figg WD, et al. Evaluation of entinostat alone and in combination with standard-of-care cytotoxic agents against rhabdomyosarcoma xenograft models. Pediatr Blood Cancer 2019;66:e27820.
• Lampert EJ, Hays JL, Kohn EC, Annunziata CM, Minasian L, Yu M, Gordon N, Sissung TM, Chiou VL, Figg WD, et al. Phase I/Ib study of olaparib and carboplatin in heavily pretreated recurrent high-grade serous ovarian cancer at low genetic risk. Oncotarget 2019;10:2855-68.
• Li M, Nguyen L, Subramaniyan B, Bio M, Peer CJ, Kindrick J, Figg WD, et al. PBPK modeling-based optimization of site-specific chemo-photodynamic therapy with far-red light-activatable paclitaxel prodrug. J Control Release 2019;308:86-97.
• Peer CJ, Schmidt KT, Kindrick JD, Eisner JR, Brown VV, Baskin-Bey E, Madan R, Figg WD. A population pharmacokinetic analysis of the oral CYP17 lyase and androgen receptor inhibitor seviteronel in patients with advanced/metastatic castration-resistant prostate cancer or breast cancer. Cancer Chemother Pharmacol 2019 Jul 31. [Epub ahead of print]
• Ramaswami R, Uldrick TS, Polizzotto MN, Wyvill KM, Goncalves P, Widell A, Lurain K, Steinberg SM, Figg WD, et al. A pilot study of liposomal doxorubicin combined with bevacizumab followed by bevacizumab monotherapy in patients with advanced Kaposi sarcoma. Clin Cancer Res 2019;25:4238-47.
• Sissung TM, Huang PA, Hauke RJ, McCrea EM, Peer CJ, Barbier RH, Strope JD, Ley AM, Zhang M, Hong JA, Venzon D, Jackson JP, Brouwer KR, Grohar P, Glod J, Widemann BC, Heller T, Schrump DS, Figg WD. Severe hepatotoxicity of mithramycin therapy caused by altered expression of hepatocellular bile transporters. Mol Pharmacol 2019;96:158-67.
• Sissung TM, Huang PA, Strope JD, Figg WD. How do you take your coffee? Lancet Oncol 2019;20:913-4.
• Sissung TM, Rajan A, Blumenthal GM, Liewehr DJ, Steinberg SM, Berman A, Giaccone G, Figg WD. Reproducibility of pharmacogenetics findings for paclitaxel in a heterogeneous population of patients with lung cancer. PLoS One 2019;14:e0212097.
• Sissung TM, Schmidt KT, Figg WD. Insulin potentiation therapy for cancer? Lancet Oncol 2019;20:191-2.
• Zimmer AS, Nichols E, Cimino-Mathews A, Peer C, Cao L, Lee MJ, Kohn EC, Annunziata CM, Lipkowitz S, Trepel JB, Sharma R, Mikkilineni L, Gatti-Mays M, Figg WD, et al. A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1-3 inhibitor, cediranib, in recurrent women’s cancers with biomarker analyses. J Immunother Cancer 2019;7:197.
• Machiela MJ, Myers TA, Lyons CJ, Koster R, Figg WD Jr, et al. Detectible mosaic truncating PPM1D mutations, age and breast cancer risk. J Hum Genet 2019;64:545-50.
• Hussain MJ, Robinson MM, Hamadeh IS, et al. Daratumumab, pomalidomide and dexamethasone combination therapy in daratumumab and/or pomalidomide refractory multiple myeloma. Br J Haematol 2019;186:140-4.
• Hamadeh IS, Zhang Q, Steuerwald N, et al. Effect of CYP3A4, CYP3A5, and ABCB1 polymorphisms on intravenous tacrolimus exposure and adverse events in adult allogeneic stem cell transplant patients. Biol Blood Marrow Transplant 2019;25:656-63.
• Yang G, Singh S, Chen Y, Hamadeh IS, et al. Pharmacogenomics of osteonecrosis of the jaw. Bone 2019;124:75-82.
• Harvey RD, Zhang C, Lonial S, et al. Reply to African American patients may or may not have poorer response rates after monoclonal antibody treatment: overreliance on P values in underpowered studies. Cancer 2019 Mar 28. [Epub ahead of print]
• Cook JW, McGrath MK, Dixon MD, Switchenko JM, Harvey RD, et al. Academic oncology clinicians’ understanding of biosimilars and information needed before prescribing. Ther Adv Med Oncol 2019;11.
• Faessel H, Nemunaitis J, Bauer TM, Lockhart AC, Faller DV, Sedarati F, Zhou X, Venkatakrishnan K, Harvey RD. Effect of CYP3A inhibitors on the pharmacokinetics of pevonedistat in patients with advanced solid tumours. Br J Clin Pharmacol 2019;85:1464-73.
• Grande E, Harvey RD, You B, et al. Pharmacokinetic study of osimertinib in cancer patients with mild or moderate hepatic impairment. J Pharmacol Exp Ther 2019;369:291-9.
• Gupta N, Hanley MJ, Xia C, Labotka R, Harvey RD, et al. Clinical pharmacology of ixazomib: the first oral proteasome inhibitor. Clin Pharmacokinet 2019;58:431-49.
• Mimche SM, Lee CM, Liu KH, Mimche PN, Harvey RD, et al. A non-lethal malarial infection results in reduced drug metabolizing enzyme expression and drug clearance in mice. Malar J 2019;18:234.
• Moore DC, Arnall JR, Harvey RD. Incidence and management of adverse events associated with panobinostat in the treatment of relapsed/refractory multiple myeloma. J Oncol Pharm Pract 2019;25:613-22.
• Ou Y, Xu Y, Gore L, Harvey RD, et al. Physiologically based pharmacokinetic modelling to predict oprozomib CYP3A drug-drug interaction potential in patients with advanced malignancies. Br J Clin Pharmacol 2019;85:530-9.
• Saba NF, Force S, Staley C, Fernandez F, Willingham F, Pickens A, Cardona K, Chen Z, Goff L, Cardin D, Lambright E, Nesbitt J, Krasinskas A, Higgins K, Harvey RD, et al. Phase IB study of induction chemotherapy with XELOX, followed by radiation therapy, carboplatin, and everolimus in patients with locally advanced esophageal cancer. Am J Clin Oncol 2019;42:331-6.
• Shteamer JW, Harvey RD, Spektor B, et al. Safety of intranasal ketamine for reducing uncontrolled cancer-related pain: protocol of a phase I/II clinical trial. JMIR Res Protoc 2019;8:e12125.
• Hickey E, Clemons B, Griffin S, et al. Multicenter evaluation of arsenic trioxide dosing in obese patients with low-intermediate risk acute promyelocytic leukemia. Leuk Lymphoma 2019;1-4.
• Hicks JK, McLeod HL. Probabilistic medicine: a pre-emptive approach is needed for cancer therapeutic risk mitigation. Biomark Med 2019;13:987-90.
• Cavallari LH, Van Driest SL, Prows CA, Bishop JR, Limdi NA, Pratt VM, Ramsey LB, Smith DM, Tuteja S, Duong BQ, Hicks JK, Lee JC, Obeng AO, Beitelshees AL, Bell GC, Blake K, Crona DJ, et al.; IGNITE Network. Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing. Genet Med 2019 Mar 21. [Epub ahead of print]
• Levy KD, Blake K, Fletcher-Hoppe C, Franciosi J, Goto D, Hicks JK, et al. Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE Network. Genet Med 2019;21:743-7.
• Bindal P, Jalil SA, Holle LM, et al. Potential role of rituximab in metastatic castrate-resistant prostate cancer. J Oncol Pharm Pract 2019;25:1509-11.
• Puri S, Holle LM, Forouhar FA, et al. Subcutaneous metastasis from recurrent basaloid squamous cell carcinoma of the esophagus. J Oncol Pharm Pract 2019;25:492-6.
• Segal ME, Bates J, Fleszar SL, Holle LM, et al. Demonstrating the value of the oncology pharmacist within the healthcare team. J Oncol Pharm Pract 2019 Jul 9. [Epub ahead of print]
• Hoshitsuki K, Crews KR, Yang W, et al. Challenges in clinical implementation of CYP2D6 genotyping: choice of variants to test affects phenotype determination. Genet Med 2019 Jul 25. [Epub ahead of print]
• Howard A, Brant JM. Pharmacologic management of cancer pain. Semin Oncol Nurs 2019;35:235-40.
• Howard A, Kerr J, McLain M, et al. Financial impact from in-office dispensing of oral chemotherapy. J Oncol Pharm Pract 2019;25:1570-5.
• Ganetsky A, Han JH, Hughes ME, et al. Oral vancomycin prophylaxis is highly effective in preventing Clostridium difficile infection in allogeneic hematopoietic cell transplant recipients. Clin Infect Dis 2019;68:2003-9.
• La-Beck NM, Liu X, Wood LM. Harnessing liposome interactions with the immune system for the next breakthrough in cancer drug delivery. Front Pharmacol 2019;10:220.
• Trinh S, Le A, Gowani S, La-Beck NM. Management of immune-related adverse events associated with immune checkpoint inhibitor therapy: a mini-review of current clinical guidelines. Asia Pac J Oncol Nurs 2019;6:154-60.
• Lee BJ, Wang SK, Constantino-Corpuz JK, et al. Cefazolin vs. anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections in acutely ill adult patients: results of a systematic review and meta-analysis. Int J Antimicrob Agents 2019;53:225-33.
• Miao E, Seetharamu N, Sullivan K, Eng S, Lee CS. Impact of tyrosine kinase inhibitor starting dose on outcomes in patients with non–small cell lung cancer. J Pharm Pract 2019 Jun 5. [Epub ahead of print]
• Elkrief A, El Raichani L, Richard C, Messaoudene M, Belkaid W, Malo J, Belanger K, Miller W, Jamal R, Letarte N, et al. Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors. Oncoimmunology 2019;8:e1568812.
• Ma D, Wong W, Aviado J, et al. Safety and tolerability of accelerated infliximab infusions in patients with inflammatory bowel disease. Am J Gastroenterol 2019;114:352-4.
• Ramakrishnan VG, Miller KC, Macon EP, et al. Histone deacetylase inhibition in combination with MEK or BCL-2 inhibition in multiple myeloma. Haematologica 2019 Mar 7. [Epub ahead of print]
• McCune JS, Quinones CM, Ritchie J, et al. Harmonization of busulfan plasma exposure unit (BPEU): a community-initiated consensus statement. Biol Blood Marrow Transplant 2019 May 25. [Epub ahead of print]
• McCune JS, Wang T, Bo-Subait K, Aljurf M, Beitinjaneh A, Bubalo J, et al. Association of antiepileptic medications with outcomes after allogeneic hematopoietic cell transplantation with busulfan/cyclophosphamide conditioning. Biol Blood Marrow Transplant 2019;25:1424-31.
• Bekaii-Saab TS, Ou FS, Ahn DH, Boland PM, Ciombor KK, Heying EN, Dockter TJ, Jacobs NL, Pasche BC, Cleary JM, Meyers JP, Desnoyers RJ, McCune JS, et al. Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study. Lancet Oncol 2019;20:1070-82.
• Chen YB, Elias N, Heher E, McCune JS, et al. Haploidentical hematopoietic cell and kidney transplantation for hematological malignancies and end-stage renal failure. Blood 2019;134:211-5.
• Cox EJ, Maharao N, Patilea-Vrana G, Unadkat JD, Rettie AE, McCune JS, et al. A marijuana-drug interaction primer: precipitants, pharmacology, and pharmacokinetics. Pharmacol Ther 2019 May 6. [Epub ahead of print]
• Kellogg JJ, Paine MF, McCune JS, et al. Selection and characterization of botanical natural products for research studies: a NaPDI center recommended approach. Nat Prod Rep 2019;36:1196-221.
• Min AC, Andres JL, Grover AB, Megherea O. Pharmacist comfort and awareness of HIV and HCV point-of-care testing in community settings. Health Promot Pract 2019 Jul 1. [Epub ahead of print]
• Dombrowski L, Mohassel L. Outcomes in obese patients undergoing induction therapy for acute leukemia. J Oncol Pharm Pract 2019;25:1058-65.
• Moore DC, Gebru T, Muslimani A. Fostamatinib for the treatment of immune thrombocytopenia. Am J Health Syst Pharm 2019;76:789-94.
• Moore DC, Gebru T, Pellegrino A, et al. Neutropenia-associated outcomes in breast cancer patients receiving myelosuppressive chemotherapy with reduced doses of pegfilgrastim. J Pharm Pract 2019 Mar 27. [Epub ahead of print]
• Patel J, Rainess RA, Benfield MJ, Rogers KML, Moore DC, Larck C, Arnall JR. Retrospective analysis of clinical outcomes associated with the use of pegfilgrastim on-body injector in patients receiving chemotherapy requiring granulocyte colony-stimulating factor support. Hosp Pharm 2019 Aug 2. [Epub ahead of print]
• An G, Murry DJ, Gajurel K, et al. Pharmacokinetics, safety, and tolerability of oxfendazole in healthy volunteers: a randomized, placebo-controlled first-in-human single-dose escalation study. Antimicrob Agents Chemother 2019;63(4).
• D’Cunha RR, Murry DJ, An G. Nilotinib alters the efflux transporter-mediated pharmacokinetics of afatinib in mice. J Pharm Sci 2019 Jun 1. [Epub ahead of print]
• Edi C, Bjerum CM, Ouattara AF, Chhonker YS, Penali LK, Méité A, Koudou BG, Weil GJ, King CL, Murry DJ. Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d’Ivoire. PLoS Negl Trop Dis 2019;13:e0007325.
• Haney SL, Chhonker YS, Varney ML, Talmon G, Smith LM, Murry DJ, et al. In vivo evaluation of isoprenoid triazole bisphosphonate inhibitors of geranylgeranyl diphosphate synthase: impact of olefin stereochemistry on toxicity and biodistribution. J Pharmacol Exp Ther 2019 Aug 16. [Epub ahead of print]
• Haney SL, Varney ML, Chhonker YS, Shin S, Mehla K, Crawford AJ, Smith HJ, Smith LM, Murry DJ, et al. Inhibition of geranylgeranyl diphosphate synthase is a novel therapeutic strategy for pancreatic ductal adenocarcinoma. Oncogene 2019;38:5308-20.
• Haney SL, Varney ML, Safranek HR, Chhonker YS, G-Dayanandan N, Talmon G, Murry DJ, et al. Tropolone-induced effects on the unfolded protein response pathway and apoptosis in multiple myeloma cells are dependent on iron. Leuk Res 2019;77:17-27.
• Rodrigues de Almeida N, Catazaro J, Krishnaiah M, Singh Chhonker Y, Murry DJ, et al. Understanding interactions of citropin 1.1 analogues with model membranes and their influence on biological activity. Peptides 2019;119:170119.
• Zhang Y, Bala V, Mao Z, Chhonker YS, Murry DJ. A concise review of quantification methods for determination of vitamin K in various biological matrices. J Pharm Biomed Anal 2019;169:133-41.
• Chen B, Nagai S, Armitage JO, Witherspoon B, Nabhan C, Godwin AC, Yang YT, Kommalapati A, Tella SH, DeAngelis C, Raisch DW, Sartor O, Hrushesky WJ, Ray PS, Yarnold PR, Love BL, Norris LB, et al. Regulatory and clinical experiences with biosimilar filgrastim in the U.S., the European Union, Japan, and Canada. Oncologist 2019;24:537-48.
• Georgantopoulos P, Yang H, Norris LB, et al. Major hemorrhage in chronic lymphocytic leukemia patients in the US Veterans Health Administration system in the pre-ibrutinib era: incidence and risk factors. Cancer Med 2019;8:2233-40.
• Chen J, Pan J, Zhan T, Tuazon S, Saini N, O’Hara W, et al. Autologous stem cell transplantation for multiple myeloma: growth factor matters. Biol Blood Marrow Transplant 2019 Jun 4. [Epub ahead of print]
• Okumura LM, da Silva Ries SA, Meneses CF, et al. Adverse events associated with aprepitant pediatric bone cancer patients. J Oncol Pharm Pract 2019;25:735-8.
• Feiten HDS, Okumura LM, Martinbiancho JK, et al. Vancomycin-associated nephrotoxicity and risk factors in critically ill children without preexisting renal injury. Pediatr Infect Dis J 2019;38:934-8.
• Rayner P, Spruit JL, Chu R, et al. Role of initiating supportive care preceding veno-occlusive disease diagnosis following allogeneic hematopoietic stem cell transplantation in children. J Pediatr Hematol Oncol 2019;41:e395-e401.
• Robinson KM, Yang W, Karol SE, et al. No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy. Pediatr Blood Cancer 2019;66:e27681.
• Viaene AN, Zhang B, Martinez-Lage M, Xiang C, Tosi U, Thawani JP, Gungor B, Zhu Y, Roccograndi L, et al. Transcriptome signatures associated with meningioma progression. Acta Neuropathol Commun 2019;7(1).
• Saadeh C, Bright D, Rustem D. Precision medicine in oncology pharmacy practice. Acta Med Acad 2019;48:90-104.
• Lahrman R, Johnson A, Heaton PC, Frede SM, Schwartz R. Assessment of community pharmacists’ confidence, foundational knowledge, and coordination of care activities in patients with cancer as a chronic condition. J Am Pharm Assoc (2003). 2019;59(4 suppl):S106-S111.e2.
• Tollkuci E, Seddon A, Geswein L, Mulseh M. Midostaurin administration in two hemodialysis patients. J Oncol Pharm Pract 2019;25:1285-8.
• Smith JA, Le T, Martin GA, et al. Identifying the need to refine the potential patient risk factors for niraparib-induced thrombocytopenia. Gynecol Oncol 2019;152:265-9.
• Smith JA, Mathew L, Gaikwad A, et al. From bench to bedside: evaluation of AHCC supplementation to modulate the host immunity to clear high-risk human papillomavirus infections. Front Oncol 2019;9:173.
• Salyakina D, Roy S, Wang W, Oliva M, Akhouri R, Sotto I, et al. Results and challenges of cytochrome P450 2D6 (CYP2D6) testing in an ethnically diverse South Florida population. Mol Genet Genomic Med 2019;7:e922.
• Sweiss K, Calip GS, Johnson JJ, et al. Pretransplant hemoglobin and creatinine clearance correlate with treatment-free survival after autologous stem cell transplantation for multiple myeloma. Bone Marrow Transplant 2019 Aug 6. [Epub ahead of print]
• Sweiss K, Calip GS, Oh AL, et al. Renal dysfunction within 90 days of FluBu4 predicts early and late mortality. Bone Marrow Transplant 2019;54:980-6.
• Sweiss K, Calip GS, Wirth S, et al. Polypharmacy and potentially inappropriate medication use is highly prevalent in multiple myeloma patients and is improved by a collaborative physician-pharmacist clinic. J Oncol Pharm Pract 2019 Jun 12. [Epub ahead of print]
• Sweiss K, Oh A, Calip GS, et al. Superior survival in African American patients who underwent autologous stem cell transplantation for multiple myeloma. Clin Lymphoma Myeloma Leuk 2019;19:e506-e511.
• Saffore CD, Ko NY, Holmes HM, Patel PR, Sweiss K, et al. Treatment of older patients with diffuse large B-cell lymphoma and mild cognitive impairment or dementia. J Geriatr Oncol 2019;10:510-3.
• Calip GS, Moran KM, Sweiss KI, et al. Myelodysplastic syndrome and acute myeloid leukemia after receipt of granulocyte colony-stimulating factors in older patients with non-Hodgkin lymphoma. Cancer 2019;125:1143-54.
• Lee I, Adimadhyam S, Nutescu EA, Zhou J, Asfaw AA, Sweiss KI, et al. Bevacizumab use and the risk of arterial and venous thromboembolism in patients with high-grade gliomas: a nested case-control study. Pharmacotherapy 2019 Jul 22. [Epub ahead of print]
• Goo K, Uy R, Roswarski J. Azacitidine-associated pleuropericardial effusion in myelodysplastic syndrome: a case report. J Oncol Pharm Pract 2019;25:1248-52.
• Poirier RH, Brown CS, Baggenstos YT, Walden SG, et al. Impact of a pharmacist-directed pain management service on inpatient opioid use, pain control, and patient safety. Am J Health Syst Pharm 2019;76:17-25.
• Chon HS, Sehovic M, Marchion D, Walko C, et al. Biologic mechanisms linked to prognosis in ovarian cancer that may be affected by aging. J Cancer 2019;10:2604-18.
• Fradley MG, Gliksman M, Emole J, Viganego F, Rhea I, Welter-Frost A, Armanious M, Lee DH, Walko C, et al. Rates and risk of atrial arrhythmias in patients treated with ibrutinib compared with cytotoxic chemotherapy. Am J Cardiol 2019;124:539-44.
• Bridge JA, Sumegi J, Druta M, Bui MM, Henderson-Jackson E, Linos K, Baker M, Walko CM, et al. Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma. Mod Pathol 2019 Jun 12. [E pub ahead of print]
• Anghelescu DL, Pankayatselvan V, Nguyen R, Ward D, et al. Bisphosphonate use in pediatric oncology for pain management. Am J Hosp Palliat Care 2019;36:138-42.
• Smith AW, Bodas P, Sidebotham L, Weilnau J, et al. Improving uptake of hydroxyurea in patients with sickle cell disease: a retrospective study of a clinic-based change in consenting practices. J Natl Med Assoc 2019;111:169-75.
• Smith T, Kokotajlo S, Lise J, Passerrello N, Weilnau J, et al; Advocacy Committee for the Pediatric Pharmacy Advocacy Group. Standardization of concentrations for extemporaneously compounded oral liquid medications. J Pediatr Pharmacol Ther 2019;24:327-9.
• Sicklick JK, Kato S, Okamura R, Schwaederle M, Hahn ME, Williams CB, et al. Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study. Nat Med 2019;25:744-50.
• Kelley KA, Sweet BV, Janke KK, Plake KS, Yee GC. Employment trends for doctor of pharmacy graduates of research-intensive institutions, 2013-2017. Am J Pharm Educ 2019;83:6864.

Promotions

• Jennifer Geyston: Lead Transplant Pharmacist, University of Virginia Health Systems.

Grants

• Chandran M, co-investigator. Bock M, primary investigator. Transitioning to Adult Transplant Care. Children’s Hospital Colorado. Funded by: Donor Alliance Foundation.
• Moss M, site investigator. Goebel J, primary investigator. Kidney Immunosuppression Dosed Daily Only (KIDDO). Children’s Hospital Colorado, Denver, Colorado. Funded by: Veloxis Pharmaceuticals.

Publications

• Bartlett FE, Carthon CE, Hagopian JC, et al. Tacrolimus concentration-to-dose ratios in kidney transplant recipients and relationship to clinical outcomes. Pharmacotherapy 2019;39:827-36.
• Chandran MM. Management of the organ donor. In: Buck ML, Lee BL, eds. Pediatric Self-Assessment Program, 2019 Book 2. Transplantation. Lenexa, KS: American College of Clinical Pharmacy. 2019:145-50.
• Strommen A, Moss M, Goebel J, et al. Donor-specific antibodies in a pediatric kidney transplant population – prevalence and association with antiproliferative drug dosing. Pediatr Transplant 2019;23:e13511.
• Lim MA, Sawinski D, Trofe-Clark J. Safety, effectiveness and tolerability of patiromer in kidney transplant recipients. Transplantation 2019;103:e281-e282.

Invited Presentations

• Jennifer Geyston: Banker’s hours no more: weekend and holiday transplant pharmacist solutions. American Transplant Congress (ATC); Boston, MA.
• Alicia Lichvar: Measuring and reversing direct acting oral anticoagulants. American Transplant Congress (ATC); Boston, MA
• Mary Moss Chandran:
  

  Conversion to improve adherence: change in formulation or agent immunosuppression in 2019 and beyond: considerations for CNI conversion. American Transplant Congress (ATC); Boston, MA.

  Impact of once-daily tacrolimus on trough concentration variability in stable adolescent and young adult renal transplant recipients. American Transplant Congress (ATC); Boston, MA.

  Impact of once-daily tacrolimus on trough concentration variability in stable adolescent and young adult renal transplant recipients. Congress of the International Pediatric Transplant Association (IPTA); Vancouver, British Columbia, Canada.

• Jennifer Trofe-Clark: Patient educational information on dietary supplements and medical marijuana. International Vasculitis Symposium, Minneapolis, MN, and participation in panel discussion.

Poster/Platform Presentations

• Lichvar A, Campara M, Benedetti E, Benken J. The implementation and impact of an opioid minimization protocol in an urban renal transplant population. American Transplant Congress (ATC); June 2019; Boston, MA.
• Moss Chandran M, Steinberg E, Sikora A, et al. Implementation of a longitudinal comprehensive multidisciplinary transition program and seminar – safely making the long leap to the adult world. American Transplant Congress (ATC); June 2019; Boston, MA.
• Moss Chandran M, Steinberg E, Sikora A, et al. Implementation of a longitudinal comprehensive multidisciplinary transition program and seminar – safely making the long leap to the adult world. Congress of the International Pediatric Transplant Association (IPTA); May 2019; Vancouver, British Columbia, Canada.
• Patel S, Khalil K, Lichvar A, Benedetti E, West-Thielke P. Time within therapeutic range: a comparison of three tacrolimus formulations within ninety days of renal transplant. American Transplant Congress (ATC); June 2019; Boston, MA.
• Reticker A, Lichvar A, Gross A, Benedetti E, Patel S. The significance and impact of screening preservation fluid cultures in renal transplant recipients. American Transplant Congress (ATC); June 2019; Boston, MA.
• Tejani K, Benedetti E, Lichvar A. Alemtuzumab versus anti-thymocyte globulin induction in the setting of immediate post-renal transplant acute tubular necrosis in an urban, minority patient population. American Transplant Congress (ATC); June 2019; Boston, MA.
• Tejani K, Hajjiri Z, Benedetti E, Lichvar A. Clinical outcomes and risk factors for delayed or slow graft function in an adult, urban renal transplant population. American Transplant Congress (ATC); June 2019; Boston, MA.
• Valdepenas B, Benken J, Benedetti E, Hajjiri Z, Lichvar A. Clinical implications of belatacept conversion in a high-risk, urban renal transplant population. American Transplant Congress (ATC); June 2019; Boston, MA.

The ID PRN continues to build on its previous successes. Members continue to excel and, in particular, achieve BCIDP status. Look for future recertification opportunities with the brand new IDSAP home study materials! Below is a sampling of professional achievements by ID PRN members.

Promotions

• Thamer Almangour: Assistant Professor, Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
• Mario Beccari: Clinical Assistant Professor of Infectious Diseases, D’Youville College School of Pharmacy, Buffalo, New York.
• Rachel Britt: Pharmacy Clinical Practice Specialist – Infectious Diseases at UTMB Health – Galveston, Texas.
• Elias Chahine: Professor of Pharmacy Practice, Palm Beach Atlantic University, the Lloyd L. Gregory School of Pharmacy.
• Timothy Gauthier: Clinical Manager of Antimicrobial Stewardship Programs for Baptist Health South Florida.
• Alan Gross: Clinical Associate Professor, University of Illinois at Chicago, College of Pharmacy.
• Monica Mahoney: Clinical Pharmacy Specialist, Outpatient ID & OPAT Clinics, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
• Drew Zimmer: ID Pharmacist at CoxHealth System, Springfield, Missouri.

Board Certification in Infectious Diseases (BCIDP)

• Thamer Almangour
• Lisa Avery
• Nika Bejou
• Josh Caraccio
• Amy Carr
• Rebecca Cofsky
• Laura Cwengros
• Wasim El Nekidy
• Madeline King
• Jenna Lopez
• Krutika Mediwala
• Kayla Stover

Awards

• Sara Alosaimy: Wayne State University International Postdoc Award 2019; ID Week Trainee Travel Award; American Society of Microbiology Fellow Travel Award.
• Amanda Barner: Cambridge Public Health Department – Public Health Hero.
• Jim Beardsley: Dean’s Award for Teaching Excellence (Wake Forest School of Medicine).
• Elias Chahine: Fellow, Florida Society of Health-System Pharmacists.
• Daniel Chastain: Preceptor of the Year, PGY1 Pharmacy Practice Residency, Phoebe Putney Memorial Hospital/University of Georgia College of Pharmacy.
• Matthew Davis: PGY2 Resident of the Year (UC Davis); most impactful research project (UC Collaborative Research Conference).
• Madeline King: Bright Idea Award for incorporating Twitter into APPE student rotations.
• Le Bonheur Antimicrobial Stewardship Program won “The Quality Cup Award – Greater Memphis Chamber – Summit level (highest level)” for Reducing Use of Broad-Spectrum Antibiotics (Kelley Lee, Jeremy Stultz, Chasity Shelton, Bindiya Bagga, and Sandra Arnold).
• Melanie Mahoney: University of Minnesota College of Pharmacy Alumni Society Student Award; Health-System Pharmacist of the Year, Massachusetts Society of Health-System Pharmacists.
• Krutika Mediwala: Lowcountry Elective Preceptor of the Year, Palmetto Experiential Education Partnership (PEEP); Young Pharmacist of the Year, SC Society of Health-System Pharmacists.
• Paula Politis: Health-System Pharmacist of the Year, Ohio Society of Health-System Pharmacists.
• Kayla Stover: Faculty Service Award.
• Tracy Zembles: SHEA “Race Against Resistance” Education Scholarship.

Grants

• Elias Chahine: Palm Beach Atlantic University Quality Initiative Grant.
• Chris Destache: Competitive internal grant mechanism.
• Brandon Dionne: ASHP Foundation Pharmacy Resident Practice-Based Research Grant.
• Debra Goff
• Melanie Mahoney: Melendy/Peters Research Scholarship.
• Michelle Martin: Hepatitis C research. Funded by: Merck.
• Kayla Stover: Educational grant to implement a new teaching initiative.

Publications

• Alghanem SS, Touw DJ, Thomson AH. Pharmacokinetic-pharmacodynamic analysis of weight and height scaled tobramycin dosage regimens for patients with cystic fibrosis. Accepted in J Antimicrob Chemother 2019;74:2311-7.
• Almangour T, Asher GN, Corbett A. Botanicals for common infections. In: Hume A, Orr K, eds. Principles and Practice of Botanicals as an Integrative Therapy. Boca Raton, FL: CRC Press, 2019:243-70.
• Almangour TA, Perry GK, Terriff CM, et al. Dalbavancin for the management of gram-positive osteomyelitis: effectiveness and potential utility. Diag Microbiol Infect Dis 2019;93:213-8.
• Alessa MA, Almangour TA, Alhossan A, et al. Ceftolozane-tazobactam for the treatment of multidrug-resistant Pseudomonas aeruginosa pneumonia in a patient receiving intermittent hemodialysis. Am J Health Syst Pharm 2018;75:e184-e188.
• Alghamdi W, Alsultan A, Al-Shaer M, et al. Cycloserine population pharmacokinetics and pharmacodynamics in patients with tuberculosis. Antimicrob Agents Chemother 2019;63:e00055-19.
• Al-Shaer MH, Alghamdi WA, Alsultan A, et al. Fluoroquinolones in drug-resistant tuberculosis: culture conversion and pharmacokinetic/pharmacodynamic target attainment to guide dose selection. Antimicrob Agents Chemother 2019;63:e00279-19.
• Al-Shaer MH, Alghamdi WA, Graham E, et al. Meropenem, cefepime, and piperacillin protein-binding in patient samples. Ther Drug Monit 2019 Jul 15. [Epub ahead of print]
• Avery L, Hoffmann C, Whalen K. The use of aerosolized ribavirin in respiratory syncytial virus lower respiratory tract infections in adult immunocompromised patients – a systematic review. Hosp Pharm 2019 Mar 27. [Epub ahead of print]
• Barber KE, Albrecht S, Stover KR. Successful treatment of persistent cryptococcal meningitis with antiretroviral therapy and alternative antifungals. J Pharmacol Pharmacother 2019;10:35-7.
• Barber KE, Wagner JL, Stover KR. Impact of obesity on acyclovir-induced nephrotoxicity. Open Forum Infect Dis 2019;6:ofz121.
• Rastas C, Sirignano D, Barner A, et al. Legionella infection associated with dimethyl fumarate used for treatment of multiple sclerosis. J Neurol 2019 Jul 26. [Epub ahead of print]
• Beccari MV, Mogle BT, Sidman EF, Mastro KA, Asiago-Reddy EA, Kufel WD. Ibalizumab: a novel monoclonal antibody for the management of multidrug-resistant HIV-1 infection. Antimicrob Agents Chemother 2019;63:e00110-19.
• Mogle BT, Beccari MV, Fazili T, Steele JM, Kufel WD. Clinical considerations for oral beta-lactams as step-down therapy for Enterobacteriaceae bloodstream infections. Expert Opin Pharmacother 2019;20:903-7.
• Beganovic M, McCreary EK, Mahoney MV, Dionne B, Green DA, Timbrook TT. Interplay between rapid diagnostic tests (RDTs) and antimicrobial stewardship programs (ASPs) among patients with bloodstream and other severe infections. J Applied Lab Med 2019;3:601-616.
• Wright WF, Bejou N, Shields RK, et al. Amphotericin B induction with voriconazole consolidation as salvage therapy for FKS-associated echinocandin resistance in Candida glabrata septic arthritis and osteomyelitis. Antimicrob Agents Chemother 2019;63:e00512-19.
• Bernard S, Kuper K, Lee KB, Stevens MP, Hohmann SF, Nguyen N, Pakyz AL. Association between meeting core elements for inpatient antimicrobial stewardship and antibiotic utilization. Infect Control Hosp Epidemiol 2019;40:1050-2.
• Hawkins WA, Smith SE, Sikora A, Carr J, Bland CM, et al. Fluid stewardship during critical illness: a call to action. J Pharm Pract 2019 Jun 30. [Epub ahead of print]
• Britt RS, Mahoney MV, McCoy C. Successful rifampin administration after rifabutin-induced leukopenia. Ann Pharmacother 2019 Jul 31. [Epub ahead of print]
• Britt RB, Pearson JC, Mahoney MV, Carlson AC. Probable ceftaroline-induced thrombocytopenia: a case report. Ann Pharmacother 2019;53:762-3.
• Alsharif NZ, Brennan L, Abrons JP, Chahine EB. An introduction to cultural sensitivity and global pharmacy engagement. Am J Pharm Educ 2019;83:7221.
• Alsharif NZ, Khanfar NM, Brennan LF, Chahine EB, et al. Cultural sensitivity and global pharmacy engagement in the Arab world. Am J Pharm Educ 2019;83:7228.
• Alsharif NZ, Khanfar NM, Brennan LF, Chahine EB, et al. Cultural sensitivity and global pharmacy engagement in the United States. Am J Pharm Educ 2019;83:7220.
• Caudle KE, Gammal RS, Karnes JH, Afanasjeva J, Anderson KC, Barreto EF, Beavers C, Bhat S, Birrer KL, Chahine EB, et al. PRN opinion paper: application of precision medicine across pharmacy specialty areas. J Am Coll Clin Pharm 2019;2:288-302.
• Dougherty JA, Sucher AJ, Chahine EB, et al. Omadacycline: a new tetracycline antibiotic. Ann Pharmacother 2019;53:486-500.
• Talagtag MS, Petrillo PTS, Lajoie KS, Chahine EB. Engaging students and pharmacists in medical missions. Sr Care Pharm 2019;34:444-8.
• Chastain DB, Cluck DB, Stover KR, Lusardi KT, Marx A, Green S, Faulkner-Fennell C, Turner M, Chahine E, Bookstaver PB, Bland CM. A baker’s dozen of top antimicrobial stewardship intervention publications in 2017. Open Forum Infect Dis 2019;6:ofz133.
• Chastain DB, Giles RL, Bland CM, et al. A clinical pharmacist survey of prophylactic strategies used to prevent adverse events of lipid-associated formulations of amphotericin B. Infect Dis (Lond) 2019;51:380-3.
• Covington EW, Baldwin BJ, Warren E. Pharmacy-led β-lactam allergy interview (BLAI) reduces duration of fluoroquinolones within a community hospital. Ann Pharmacother 2019;53:588-95.
• Covington EW, Wingler MJB, Jayakumar RA, et al. Strategies for clarifying β-lactam allergies when skin testing is not an option. Pharmacy 2019;7:69.
• Davis MR, Donnelley MA, Thompson GR. Ibrexafungerp: a novel oral glucan synthase inhibitor. Med Mycol 2019 Jul 25. [Epub ahead of print]
• Nguyen MH, Davis MR, Wittenberg R, et al. Posaconazole serum drug levels associated with pseudohyperaldosteronism. Clin Infect Dis 2019 Aug 12. [Epub ahead of print]
• Destache CJ, Guervil DJ, Kaye KS. Ceftaroline fosamil for the treatment of gram-positive endocarditis: CAPTURE study experience. Int J Antimicrob Agents 2019;53:644-9.
• Cavalieri SJ, Kwon S, Vivekanandan R, Ased S, Carroll C, Anthone J, Schmidt D, Baysden M, Destache CJ. Effect of antimicrobial stewardship with rapid MALDI-TOF identification and Vitek 2 antimicrobial susceptibility testing on hospitalization outcome. Diagn Microbiol Infect Dis 2019;95:208-11.
• Mandal S, Prathipati PK, Belshan MA, Destache CJ. Potential long-acting bictegravir loaded nano-drug delivery system to prevent HIV-1 infection: a proof-of-concept study. Antivir Res 2019;167:83-8.
• Dilworth TJ, Beck E, Pederson R, et al. High rate of linezolid non-susceptibility among enteric vancomycin-resistant Enterococcus (VRE) recovered from hospitalized patients actively screened for VRE colonization. Infect Control Hosp Epidemiol 2019;40:821-2.
• Clark L, Skrupky LP, Servais R, Brummitt CF, Dilworth TJ. Examining the relationship between vancomycin area under the concentration time curve and serum trough levels in adults with presumed or documented staphylococcal infections. Ther Drug Monit 2019;41:483-8.
• Dionne B. Key principles of antiretroviral pharmacology. Infect Dis Clin North Am 2019;33:787-805.
• Dionne B, Kubiak DW. Infection prophylaxis in the immunocompromised patient. In: Murphy JE, Lee MWL, Gabardi S, eds. Current Issues in Pharmacotherapy. Pharmacotherapy Self-Assessment Program. Lenexa, KS: American College of Clinical Pharmacy; 2019.
• Eljaaly K, Enani MA. Superinfection: a forgotten quality measure of antimicrobial stewardship? APAU Spring 2019 Newsl 37:6-7.
• Eljaaly K, Wali H, Basilim A, Alharbi A, Asfour H. Clinical cure with ceftriaxone versus ceftaroline or ceftobiprole in the treatment of staphylococcal pneumonia: a systematic review and meta-analysis. Int J Antimicrob 2019;54:149-53.
• El Nekidy WS, El-Masri MM, Ghazi IM, Soong D. Factors predicting vancomycin therapy outcomes in hemodialysis outpatients and the role of the nephrology stewardship pharmacist. Hemodial Int 2019 Jul 30. [Epub ahead of print]
• Drekonja DM, Grigoryan L, Lichtenberger P, Graber CJ, Patel PK, Van JN, Dillon LM, Wang Y, Gauthier TP, et al. Teamwork and safety climate affect antimicrobial stewardship for asymptomatic bacteriuria. Infect Control Hosp Epidemiol 2019.
• Geriak M, Haddad F, Rizvi K, Rose W, Kullar R, Laplante K, et al. Clinical data on daptomycin plus ceftaroline versus standard of care monotherapy in the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2019;63:e02483-18.
• Sakoulas G, Geriak M, Nizet V. Is a reported penicillin allergy sufficient grounds to forgo the multidimensional antimicrobial benefits of β-lactam antibiotics? Clin Infect Dis 2019;68:157-64.
• Gross AE, Hanna D, Rowan SA, Bleasdale SC, Suda KJ. Successful implementation of an antibiotic stewardship program in an academic dental practice. Open Forum Infect Dis 2019;6(3).
• Sarna KV, Gross AE. Vancomycin versus metronidazole for nonsevere Clostridioides difficile infection: are the data adequate to change practice? Ann Pharmacother 2019 Feb 8. [Epub ahead of print]
• Hammond DA, McCreary EK, Rech MA, Smith MN, Yeo Q, Lusardi K, Rhodes NJ, Swanson JM, Bland CM. Perceptions and practices for beta-lactam antibiotic dosing, administration, and monitoring in critically ill patients: current views and use among critical care and infectious diseases pharmacists. J Am Coll Clin Pharm 2019 Feb 13. [Epub ahead of print]
• Jones BM, Jozefczyk C, Maguire C, Milliken S, Weisz EM, Bland CM. Beta-lactam allergy review: implications for antimicrobial stewardship programs. Curr Treat Options Infect Dis 2019;11:103.
• Johnson M, Jones BM, Heil E, Stover K, Trone S, Fulford M, Bland CM. Self-perceived knowledge and confidence regarding infectious diseases of advanced pharmacy practice students. Curr Pharm Teach Learn 2019 Aug 12. [Epub ahead of print]
• Jorgensen SC, Zasowski EJ, Trinh TD, Lagnf AM, Nhatia S, Bhatia S, Sabagha N, Abdul-Mutakabbir JC, Alosaimy S, Mynatt RP, Davis SL, Rybak MJ. Daptomycin plus beta-lactam combination therapy for methicillin-resistant Staphylococcus aureus bloodstream infections: a retrospective, comparative study. Clin Infect Dis 2019 Aug 12. [Epub ahead of print]
• King M, Rose L, Fraimow H, Nagori M, Danish M, Doktor K. Vibrio vulnificus infections from a previously nonendemic area. Ann Intern Med 2019 Jun 18. [Epub ahead of print]
• Kufel WD, Eranki AP, Paolino KP, et al. In vivo pharmacokinetic analysis of meropenem-vaborbactam during continuous renal replacement therapy. J Antimicrob Chemother 2019;74:2117-8.
• Kufel WD, Seabury RW, Mogle BT, Beccari MV, et al. Readiness to implement vancomycin monitoring based on area under the concentration-time curve: a cross-sectional survey of a national health consortium. Am J Health Syst Pharm 2019;76:889-94.
• Kirk A, Pierce J, Doll M, Lee KB, Pakyz A, et al. The effectiveness of formulary restriction and preauthorization at an academic medical center. Am J Infect Control 2019;47:837-9.
• Pierce JW, Kirk A, Lee KB, Markley J, Pakyz A, et al. The impact of formulary restriction on the relative consumption of carbapenems in intensive care units at an academic medical center. Infect Control Hosp Epidemiol 2019;40:1056-8.
• Albarillo FS, Labuszewski L, Lopez J, Santarossa M, et al. Use of a clinical decision support system (CDSS) to improve antimicrobial stewardship efforts at a single academic medical center. GERMS 2019;9:106-9.
• Mahoney MV, Bidell M. C. difficile infection. In: Dixon DL, Harris IM, eds. Ambulatory Care Self-Assessment Program, 2019 Book 2: Infection Primary Care. Lenexa, KS: American College of Clinical Pharmacy, 2019:107-131.
• Heaney M, Mahoney MV, Gallagher JC. Eravacycline: the tetracyclines strike back. Ann Pharmacother 2019;53:1124-35.
• Martin MT. Gastrointestinal disorders. In: Bainbridge JL, Cardone K, Cross LB., et al., eds. ACCP/ASHP 2019 Ambulatory Care Pharmacy Preparatory Review and Recertification Course. Lenexa, KS: American College of Clinical Pharmacy, 2019:983-1091.
• Martin MT. HCV screening: how can pharmacists get involved? Clin Care Options Online. May 21, 2019.
• Martin MT. Hepatitis C virus management in the post-pipeline era. In: Dixon DL, Harris IM, eds. Ambulatory Care Self-Assessment Program, 2019 Book 2. Infection Primary Care. Lenexa, KS: American College of Clinical Pharmacy, 2019:7-28.
• Koren D, Zuckerman A, Teply R, Nabulsi N, Lee T, Martin MT. Expanding hepatitis C virus care and cure: national experience using a clinical pharmacist-driven model. Open Forum Infect Dis 2019;6:ofz316.
• Michienzi SM, Martin MT. Hepatitis A, B, and D. In: Dodds Ashley ES, Gross AE, eds. Infectious Diseases Self-Assessment Program, 2019 Book 1. HIV and Hepatitis. Lenexa, KS: American College of Clinical Pharmacy, 2019:85-104.
• Mediwala KN. Utilizing MRSA nasal screening for antimicrobial stewardship. Contagion Live Infectious Diseases Today. July 2019.
• Mediwala KN, Kohn JE, Bookstaver PB, Justo JA, Rac H, Tucker K, Lashkova L, Dash S, Al-Hasan MN. Syndrome-specific versus prospective audit and feedback interventions for reducing use of broad-spectrum antimicrobial agents. Am J Infect Control 2019 Jun 18. [Epub ahead of print]
• Fenn NE III, Nolt VD, Mediwala KN, et al. Perceptions of the two-phase pharmacy residency match process. Am J Health Syst Pharm. In press.
• Khalil AJ, Mediwala KN, Mehta MJ, et al. Survey of residency program directors’ attitudes and perceptions of non-traditional pharmacy residency applicants. Am J Health Syst Pharm. In press.
• Nguyen CT, Davis KA. Evaluating the impact of peer comparison on vancomycin dose order verification among pharmacists. J Am Coll Clin Pharm 2019;2:137-42.
• Nguyen CT, Reuter CM, Hudson T, et al. Evaluation of surgical site infection antibiotic prophylaxis among patients receiving antibiotics for active infection. J Hosp Infect 2019 Jun 8. [Epub ahead of print]
• Pagels CM, McCreary EK, Rose WE, Dodds Ashley ES, Bookstaver PB, Dilworth TJ. Designing antimicrobial stewardship initiatives to enhance scientific dissemination. J Am Coll Clin Pharm 2019 Jul 24. [Epub ahead of print]
• Vaughan D, Pakyz A, Stevens M, Lee K, Bernard S. Adequacy of empiric gram-negative coverage for septic patients at an academic medical center. Am J Infect Control 2019 May 18. [Epub ahead of print]
• Uppala A, King EA, Patel D. Cefazolin versus fluoroquinolones for the treatment of community-acquired urinary tract infections in hospitalized patients. Eur J Clin Microbiol Infect Dis 2019;38:1533-8.
• Colby JM, Patel PC, Fu DY, et al. Commonly used fluoroquinolones cross-react with urine drug screens for opiates, buprenorphine, and amphetamines. Clin Biochem 2019;68:50-4.
• Lodise TP, Rosenkranz SL, Finnemeyer M, Evans S, Sims M, Zervos MJ, Creech CB, Patel PC, Keefer M, Riska P, Silveira FP, Scheetz M, et al.; Antibacterial Resistance Leadership Group. The emperor’s new clothes: prospective observational evaluation of the association between initial vancomycin exposure and failure rates among adult hospitalized patients with MRSA bloodstream infections (PROVIDE). Clin Infect Dis 2019 Jun 3. [Epub ahead of print]
• Stover KR, Barber KE, Wagner JL. Allergic reactions and cross-reactivity potential with beta-lactamase inhibitors. Pharmacy 2019;7:77.
• Riche DM, Stover KR, Pittman JR, et al. Admission type as a predictor of performance in a problem-based learning course series. Curr Pharm Teaching Learn 2019;11:231-5.
• Wingler MJB, Stover KR, Barber KE, Wagner JL. An evaluation of pharmacist-led interventions for inpatient HIV-related medication errors. J Pharm Technol 2019 Jun 21. [Epub ahead of print]
• Willems HME, Stultz JS, Coltrane ME, et al. Disparate Candida albicans biofilm formation in clinical lipid emulsions due to capric acid mediated inhibition. Antimicrob Agents Chemother 2019 Aug 12. [Epub ahead of print]
• Suda KJ, Calip GS, Zhou J, Rowan S, Gross AE, et al. Assessment of the appropriateness of antibiotic prescriptions for infection prophylaxis before dental procedures, 2011 to 2015. JAMA Network Open 2019;2:e193909.
• Zembles TN, Bushee G, Willoughby RW. Impact of American Academy of Pediatrics palivizumab guidance for children ≥ 29 and < 35 weeks of gestational age. J Pediatr 2019;209:125-9.
• Zembles TN, Bushee G, Willoughby RE. Reply. J Pediatr 2019 June 13. [Epub ahead of print]

New ACCP Fellows

• Lisa Avery

Other Notable Achievements

• Sara Alosaimy: Abstract Selected for Platform at 2019 SIDP Annual Meeting; Abstract selected for 2019 ACCP Annual Meeting Poster CPE Invitation.
• Amanda Barner: ID Week 2019 Poster: Evaluation of time to organism identification and pharmacist impact on antibiotic prescribing through utilization of MALDI-TOF at two community, teaching hospitals (Poster No. 2009).
• Britt RS, Gold HS, Mahoney MV, McCoy C. Poster accepted at Massachusetts Society of Health-System Pharmacists Annual Meeting 2019: Evaluation of the duration of empiric antimicrobial therapy after defervescence and no identified source of infection in patients with febrile neutropenia.
• Britt RS, Mahoney MV, Gold HS, O’Donnell JN, McCoy C: Poster accepted at IDWeek 2019: Evaluation of empiric antifungal therapy in critically ill patients with liver disease, sepsis, and no evidence of active fungal infection. Saturday, October 5, at 12:15 p.m. Poster No. 2113.
• Matthew Davis: ID Clinical Pharmacist, UCLA Ronald Reagan Medical Center.
• Brandon Dionne: 2019-20 Secretary/Treasurer of the ACCP ID PRN.
• Debra Goff: One of 25 global experts selected by the World Health Organization to help implement ASP in lower middle income countries in 2020.
• Kimberly Lee: Co-founder of the Stewardship Interest Group of Virginia (SIGoVA), with a virtual research symposia. www.vdh.virginia.gov/surveillance-and-investigation/sigova-antimicrobial-stewardship-virtual-research-symposium/
• Melanie Mahoney: Poster presentation at ECCMID: Escherichia coli ST131 in Boston vs. Minneapolis: prevalence, virulence genes, and antibiotic resistance.
• Monica Mahoney:

  2019-20 Chair-Elect of the ACCP ID-PRN.

  MSHP webinar “It’s the End of the World as We Know It: Updates on the Treatment of Gram-negative Infections.”

  MAD-ID presenter, “Short Course Therapy for Common Infections,” “Whetting Your Appetite: Current & New Therapies for Complicated Intra-abdominal Infections,” and “Formulary Management Strategies in Antimicrobial Stewardship.”

  SHEA Spring Conference presenter, “Challenging Cases: Gram-negative Infections” and “Antibiotic Stewardship in Solid Organ and Hematologic Oncology Transplant Patients.”

• Pratish Patel: AAHIVP certification.

Promotions

• Linda Awdishu: Professor of Clinical Pharmacy and Chair, Division of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego.
• Calvin Meaney: Clinical Associate Professor at University at Buffalo School of Pharmacy and Pharmaceutical Sciences.
• Timothy Nguyen: Full Professor of Pharmacy Practice (effective fall 2019), Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University.

Awards

• Ifeanyi Onor: Lawrence Ferring Faculty Award (Best Faculty), Xavier University of Louisiana (XULA) College of Pharmacy.
• Wendy St. Peter: National Kidney Foundation’s 2020 Medical Advisory Board Distinguished Service Award.

Publications

• El Nekidy WS, El-Masri MM, Ghazi IM, et al. Factors predicting vancomycin therapy outcomes in hemodialysis outpatients and the role of the nephrology stewardship pharmacist. Hemodial Int 2019 Jul 30. [Epub ahead of print]
• El-Masri MM, El Nekidy WS, Soong D, et al. Efficacy of alteplase 1 versus 2 mg dose in restoring haemodialysis catheter function (Alte-dose 2): a randomized double-blind controlled study. Nephrology (Carlton) 2019 Jul 3. [Epub ahead of print]
• Meaney CJ, Sudchada P, Consiglio JD, et al. Influence of calcineurin inhibitor and sex on mycophenolic acid pharmacokinetics and adverse effects post-renal transplant. J Clin Pharmacol 2019;59:1351-65.
• Nguyen T, Tran T, Dowling T. Principles of drug therapy in reduced kidney function. In: Lapsia V, Jaar B, Ejaz AA, eds. Kidney Protection. A Practical Guide to Preserving Renal Function in Acute and Chronic Disease. Oxford University Press, 2019:chap 21.
• Wong E, Nguyen T. Introduction of an integrated curriculum: early outcomes and experiences within a large private university. Curr Pharm Teach Learn 2019;11:528-32.

Other Notable Achievements

• Linda Awdishu:

  Appointed as Board Member, American Board of Internal Medicine, Nephrology Board.

  Appointed as a Member, American Society of Nephrology Kidney Week Programming Committee.

  Appointed to Editorial Board, American Society of Nephrology Kidney360 Journal.

• Matt Horton: Completed a nephrology pharmacy residency and started a full-time faculty position at California Northstate University in Elk Grove, California.

Publications

• Basri DS, DiScala SL, Brooks AT, et al. Analysis of inpatient hospice pharmacist interventions within a Veterans Affairs medical center. J Pain Palliat Care Pharmacother 2018;32:240-7.
• Goodlev ER, DiScala S, Darnall BD, et al. Managing cancer pain, monitoring for cancer recurrence, and mitigating risk of opioid use disorders: a team-based, interdisciplinary approach to cancer survivorship. J Palliat Med 2019 Jul 22. [Epub ahead of print]

Presentations

• Sandra DiScala, Maura Miller, Michael Silverman. A case report describing the management of intrathecal opioids in hospice care. American Academy of Hospice and Palliative Medicine Annual Meeting Assembly; March 13–16, 2019; Orlando, FL.
• Lauren Shirley, Sandra DiScala, Christine M. Vartan, Hiroko Forbes. Evaluating utilization and outcomes of the prescription drug monitoring program (PDMP) within the West Palm Beach Veterans Affairs (VA) Healthcare System. PAINWeek Conference; September 5, 2019; Las Vegas, NV.

Awards/Honors

• Kashelle Lockman: ACCP New Educator Award.

Several Pediatrics PRN subcommittees have been developing new programming and opportunities for members. Highlights are as follows:

Education Committee: Will continue to offer resident/fellow journal clubs during 2019–2020 with plans to pilot a student journal club as well. A big thank-you to the committee for all the work designing the 2019 Pediatrics PRN Focus Session – Medical Use of Cannabinoid Products in the Pediatric Population, to be offered Sunday, October 27, 2019, from 4:30 p.m. to 6:30 p.m. (EST) at the Annual Meeting.

Research Committee: Continues to support PRN members in their research and scholarly endeavors. The Pediatrics PRN is excited for the opportunity to sponsor eligible Pediatrics PRN members to participate in the ACCP FIT and/or the ACCP MeRIT program. If approved, the sponsorship will provide eligible applicants with financial support to cover part of the ACCP FIT/MeRIT tuition. More information can be found on the PRN website (http://pediprn.accp.com/).

Travel Awards Committee: Continues to support resident/fellow and student members of the PRN with an award to partly defer the costs to attend the ACCP Annual Meeting. Award recipients will be recognized at the Pediatrics PRN business meeting on Monday, October 28, 2019, from 6:30 p.m. to 8:30 p.m. (EST) at the Annual Meeting.

Social Media Committee: Check out the Facebook (https://facebook.com/accppediprn/) and Twitter (@accppediprn) accounts for up-to-date information regarding the PRN as well as pediatric pharmacy practice.

Nominations Committee: Is excited to present its recently elected officers: Deborah Bondi (chair-elect) and Cassandra Ruggles (secretary/treasurer). Thank you to all candidates who ran this year and for your continued engagement with the Pediatrics PRN!

Promotions

• Justin Cole: Chair of the Department of Pharmacy Practice for the Cedarville University School of Pharmacy.
• Peter (Pete) N. Johnson: Professor of Pharmacy Practice, the University of Oklahoma College of Pharmacy.

Awards

• Amy Kruger Howard: 2019 Ton Hoek Scholarship awarded by the American Pharmacists Association (APhA) Foundation.
• Peter (Pete) N. Johnson: President’s Associate Presidential Professor from University of Oklahoma and University of Oklahoma Health Sciences Center (award and new title for dedication to teaching and mentoring students in research).
• Ricky Ogden: University of Missouri-Kansas City School of Pharmacy 2019 Health-System Pharmacy Alumni Service Award.
• Deborah K. Pritchett: Egger Family Employee of the Year from Sanford Children’s Hospital/Sanford USD Medical Center.

Publications

• Miller JL, Ernst K, Neely SB, Stephens K, Barker P, Skrepnek GH, Johnson PN. Low-dose versus high-dose methadone for the management of neonatal abstinence syndrome. J Opioid Manag 2019;15:159-67.
• Beckman EJ. Management of the pediatric organ donor. J Pediatr Pharmacol Ther 2019;24:276-89.
• Bednarz AM, Israel EN, Beckman EJ, et al. Safety of enteral sildenafil in hemodynamically unstable children. Cardiol Young 2019;3:1-5.
• Blackmer AB, Siu A, Thornton A, Johnson PN, Nichols KR, Hagemann TM. Academic careers in pediatric pharmacy: part 2-academic advancement. J Pediatr Pharmacol Ther 2019;24:183-93.
• Siu A, Blackmer A, Thornton A, Johnson PN, Nichols K, Hagemann TM. Overview and preparation guide for academic careers in pediatric pharmacy, part 1: career as a pediatric pharmacy practice faculty member. J Pediatr Pharmacol Ther 2019;24:79-89.
• Fusco NM, Maerten-Rivera JL, Doloresco F, et al. Improving pharmacy students’ attitudes toward collaborative practice through a large-scale interprofessional forum targeting opioid dependence. Am J Pharm Educ 2019;83:Article 7034.
• Prescott WA Jr, Violanti KC, Fusco NM. Characterization of vaccination policies for attendance and employment at day/summer camps in New York State. J Pharm Pract 2019;32:382-7.
• Johnson PN, Stephens K, Barker P, Bergeron E, Lim SY, Hagemann TM, Lewis TV, et al. Prescribing patterns of continuous infusions in non-obese versus obese children admitted to the pediatric intensive care unit. J Pediatr Intensive Care 2019;1-7.
• Capino AC, Johnson PN, Williams P, et al. A pilot study comparing the Modified Finnegan Scoring System versus Adjusted Scoring System for infants with iatrogenic opioid abstinence syndrome status cardiothoracic surgery. J Pediatr Pharmacol Ther 2019;24:154-61.
• Kruger Howard A, Morgan J. To treat or triage: frequently asked questions on managing fevers in otherwise healthy children. US Pharm 2019;44:22-5.
• Sharma K, Cooke C, Kruger Howard A, et al. Beneficiary, caregiver, and case manager perspectives on the medication therapy management (MTM) program standardized format. J Gerontol Nurs 2019;45:7-13.
• Matson KL, Johnson PN, Tran V, et al. Opioid use in children. J Pediatr Pharmacol Ther 2019;24:72-5.
• Pabst D, Ogden RK. Tiered communication system for a health system pharmacy department. Am J Health Syst Pharm 2019;76:637-8.
• Sawrey EL, Subramanian MW, Ramirez KA, et al. Use of body surface area for dosing of vancomycin. J Pediatr Pharmacol Ther 2019;24:296-303.
• Stultz JS, Arnold SR, Shelton CM, Bagga B, Lee KR. Antimicrobial stewardship impact on Pseudomonas aeruginosa susceptibility to meropenem at a tertiary pediatric institution. Am J Infect Control 2019 June 25. [Epub ahead of print]
• Stultz JS, Eiland LS. Doxycycline and tooth discoloration in children: changed of recommendations based on evidence of safety. Ann Pharmacother 2019 Jul 7. [Epub ahead of print]

Other Notable Achievements

• Elizabeth Beckman: Appointed to Pediatric Critical Care Medicine journal editorial board for a 3-year term.
• Ricky Ogden: Fellow, American College of Healthcare Executives.

Members of the Perioperative Care PRN continue to be engaged in research and outreach efforts related to the care of patients undergoing surgery. The PRN’s focus session, titled “Red Light … Green Light … Red Light: Anticoagulation Challenges in the Surgical Patient,” will be held Sunday, October 27, from 2:15 p.m. to 3:45 p.m. The PRN appreciates the work of its Education Committee, led by Chair-Elect Eric Johnson. This summer, the PRN hosted two webinars, which were well attended. The PRN appreciates the expertise of its presenters, Drs. Sara Hyland and Daniel James.

Publications

• Caudle KE, Gammal RS, Karnes JH, Afanasjeva J, Anderson KC, Barreto EF, Beavers C, Bhat S, Birrer KL, et al. PRN opinion paper: application of precision medicine across pharmacy specialty areas. J Am Coll Clin Pharm 2019;2:288-302.
• Gaviola ML, Scribe EC, Leverett HN, et al. Statin effects on incidence, treatment success, and mortality of Clostridium difficile infections. J Pharm Pract 2019 Jun 19. [Epub ahead of print]
• Grass F, Lovely JK, Crippa J, et al. Comparison of recovery and outcome after left and right colectomy. Colorectal Dis 2019;21:481-6.
• Quiram BJ, Crippa J, Grass F, Lovely JK, et al. Impact of enhanced recovery on oncological outcomes following minimally invasive surgery for rectal cancer. Br J Surg 2019;106:922-9.
• Brummett C, England C, Evans-Shields J, Kong A, Lew C, Henriques C, Zimmerman N, Pawasauskas J, et al. Healthcare burden associated with outpatient opioid use following inpatient or outpatient surgery. J Manage Care Spec Pharm 2019;25:973-83.
• Prach A, Clancy A, LeBlanc M, Thomasian B, Kelley M, Hogan E, Pawasauskas J. Implementation and evaluation of an inpatient naloxone program in a community teaching hospital. Res Soc Admin Pharm 2019;15:1037-42.
• Wolfe RC. Perioperative buprenorphine. J Perianesth Nurs 2019;34:867-70.
• Wolfe RC, Evans T. Antithrombotic therapy and regional anesthesia. J Perianesth Nurs 2019;34:439-46.

Other Notable Achievements

Rachel C. Wolfe: Master’s degree in Health Administration from Webster University.

Awards

• Keito Hoshitsuki: 2019 Rho Chi – AFPE First Year Graduate Fellowship.
• Jason Karnes: New Investigator Award, American College of Clinical Pharmacy.

Grants

• Jasmine Luzum: Precision Medicine for Heart Failure: The Role of Genomics in the Efficacy and Racial Disparity of Cornerstone Pharmacotherapy. NHLBI K08. Role: principal investigator.
• Lusi Zhang: 2019 ACCP Foundation Futures Grant. Polygenic Risk for Cardiovascular Diseases, Cardiovascular Medication Burden and Cognitive Performance in Patients with Psychotic Disorders. Role: principal investigator. Mentor: Jeffrey R. Bishop.

Publications

• Alghanem SS, Touw DJ, Thomson AH. Pharmacokinetic-pharmacodynamic analysis of weight and height scaled tobramycin dosage regimens for patients with cystic fibrosis. J Antimicrob Chemother 2019;74:2311-7.
• Cavallari LH, Van Driest SL, Prows CA, Bishop JR, Limdi NA, Pratt VM, Ramsey LB, Smith DM, Tuteja S, Duong BQ, Hicks JK, Lee JC, Owusu Obeng A, Beitelshees AL, Bell GC, Blake K, Crona DJ, Dressler L, Gregg RA, Hines LJ, Scott SA, Shelton RC, Weitzel KW, Johnson JA, Peterson JF, Empey PE, Skaar TC. Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing. Genet Med 2019 Mar 21. [Epub ahead of print]
• Ramsey LB, Brown JT, Vear SI, Bishop JR, Van Driest SL. Gene-based dose optimization in children. Annu Rev Pharmacol Toxicol 2019 Jul 5. [Epub ahead of print]
• Caudle KE, Gammal RS, Karnes JH, Afanasjeva J, Anderson KC, Barreto EF, Beavers C, Bhat S, Birrer KL, Chahine EB, Ensor CR, Flowers SA, Formea CM, George JM, Gosser RA, Hebert MF, Karaoui LR, Kolpek JH, Lee JC, Leung JG, Maldonado AQ, Minze MG, Pulk RA, Shelton CM, Sheridan M, Smith MA, Soefje S, Tellez-Corrales E, Walko CM, Cavallari LH. PRN opinion paper: application of precision medicine across pharmacy specialty areas. J Am Coll Clin Pharm 2019;2:288-302.
• Caudle KE, Sangkuhl K, Whirl-Carrillo M, Swen JJ, Haidar CE, Klein TE, Gammal RS, Relling MV, Scott SA, Hertz DL, Guchelaar HJ, Gaedigk A. Standardizing CYP2D6 genotype to phenotype translation: consensus recommendations from the Clinical Pharmacogenetics Implementation Consortium (CPIC) and Dutch Pharmacogenetics Working Group (DPWG). Clin Transl Sci. In press.
• Carr RC, Leung D, Ensom MHH. Survey of therapeutic drug monitoring practices in pediatric health care programs across Canada. Can J Hosp Pharm 2019;72:126-32.
• Hong J, Lau TTL, Ensom MHH. What is the evidence for co-trimoxazole, clindamycin, doxycycline, and minocycline in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) pneumonia? Ann Pharmacother 2019;53:1153-61.
• Rong Y, Mayo P, Ensom MHH, Kiang TKL. Population pharmacokinetics of mycophenolic acid co-administered with tacrolimus in corticosteroid-free adult kidney transplant patients. Clin Pharmacokinet 2019 May 4.[Epub ahead of print]
• Gammal RS, Mayes J, Caudle KE. Ready or not, here it comes: direct-to-consumer pharmacogenomic testing and its implications for community pharmacists. J Am Pharm Assoc (2003) 2019;59:646-50.
• Desta Z, Gammal RS, Gong L, Whirl-Carrillo M, Gaur AH, Sukasem C, Hockings J, Myers A, Swart M, Tyndale RF, Masimirembwa C, Iwuchukwu O, Chirwa S, Lennox J, Gaedigk A, Klein TE, Haas DW. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2B6 and efavirenz-containing antiretroviral therapy. Clin Pharmacol Ther 2019;106:726-33.
• Hicks JK, Aquilante CL, Dunnenberger HM, Gammal RS, Funk RS, Aitken SL, Bright DR, Coons JC, Dotson KM, Elder CT, Groff LT, Lee JC. Precision pharmacotherapy: integrating pharmacogenomics into clinical pharmacy practice. J Am Coll Clin Pharm 2019;2:303-13.
• Hoshitsuki K, Crews KR, Yang W, Smith CA, Hankins JS, Turner AJ, Broeckel U, McMillin GA, Relling MV, Haidar CE. Challenges in clinical implementation of CYP2D6 genotyping: choice of variants to test affects phenotype determination. Genet Med 2019 Jul 25. [Epub ahead of print]
• Hoshitsuki K, Molinelli AR, Inaba H, Rubnitz JE, Barker, PJ. Case of metabolic acidosis in a pediatric patient with leukemia and fungal infection. Clin Chem 2019. In press.
• Hulsen T, Jamuar SS, Moody A, Karnes JH, Orsolya V, Hedensted S, Spreafico R, Hafler DA, McKinney E. From big data to precision medicine. Front Med 2019;6:34.
• Patanwala AE, Norwood C, Steiner H, Morrison D, Li M, Walsh K, Martinez M, Baker SE, Snyder EM, Karnes JH. Psychological and genetic predictors of pain tolerance. Clin Transl Sci 2019;12:189-95.
• Ramamoorthy A, Karnes JH, Finkel R, Blanchard R, Pacanowski M. Evolution of next generation therapeutics: past, present, and future of precision medicines. Clin Transl Sci 2019. In press.
• Kiang TKL, Ensom MHH. Exposure-toxicity relationships of mycophenolic acid in adult kidney transplant patients. Clin Pharmacokinet 2019 Jul 22. [Epub ahead of print]
• Rautiola D, Maglalang PD, Cheryala N, et al. Intranasal coadministration of a diazepam prodrug with a converting enzyme results in rapid absorption of diazepam in rats. J Pharmacol Exp Ther 2019 Mar 5. [Epub ahead of print]
• Cicali EJ, Weitzel KW, Elsey AR, Orlando FA, Vinson M, Mosley S, Smith DM, et al. Challenges and lessons learned from clinical pharmacogenetic implementation of multiple gene-drug pairs across ambulatory care settings. Genet Med 2019 Mar 30. [Epub ahead of print]

Other Notable Achievements

• Max Smith: Assistant Professor of Oncology at Georgetown University School of Medicine.

Awards

• Brittany Bissell: Received an Igniting Research Collaborations grant for her work in “Immunomodulatory Effects of Opioids in Sepsis.”
• Paul Boylan: Received Larkin University College of Pharmacy Teacher of the Year.

Publications

• Bissell BD, Magee C, Moran P, et al. Hemodynamic instability secondary to vasopressin withdrawal in septic shock. J Intensive Care Med 2019;34:761-5.
• Hammond DA, Sacha GL, Bissell BD, et al. Effects of norepinephrine and vasopressin discontinuation order in the recovery phase of septic shock: a systematic review and individual patient data meta-analysis. Pharmacotherapy 2019;39:544-52.
• McCleary EJ, Thompson Bastin ML, Bissell BD, et al. Development of a co-precepting model for a preceptor-in-training program for new practitioners. Hosp Pharm 2019;54:246-9.
• Newsome AS, Bissell BD, Burry LD, et al. Major publications in critical care pharmacotherapy literature in 2018. J Crit Care 2019;52:200-7.
• Woodward CW, Lambert J, Ortiz-Soriano V, Li Y, Ruiz-Conejo M, Bissell BD, et al. Fluid overload associates with major adverse kidney events in critically ill patients with acute kidney injury requiring continuous renal replacement therapy. Crit Care Med 2019 Jun 3. [Epub ahead of print]
• Boylan PM, Santibañez M. Upper gastrointestinal bleeding in a male patient taking megestrol acetate and rivaroxaban: a case report. Sr Care Pharm 2019;34:499-507.
• Boylan PM, Sedlacek J, Santibañez M, et al. Development and implementation of interprofessional relations between a college of pharmacy and osteopathic residency programs in a community teaching hospital. J Pharm Technol 2019 Jul 22. [Epub ahead of print]

Promotions

• Kylie N. Barnes: Clinical Associate Professor, University of Missouri-Kansas City School of Pharmacy.
• Sarah M. Westberg: Professor, University of Minnesota College of Pharmacy.
• Audra M. Wilson: Clinical Pharmacy Specialist, Tele-PACT/Women’s Health, VISN 20 CRH Tele-Primary Care.

Publications

• Anderson L, Hartung DM, Middleton L, et al. Pharmacist provision of hormonal contraception in the Oregon Medicaid population. Obstet Gynecol 2019;133:1231-7.
• Rodriguez MI, Darney BG, Edelman AB, Yee K, Anderson L, et al. Pharmacists expand access to reproductive healthcare: PEARL study protocol. BMC Health Serv Res 2019;19:207.
• Rodriguez MI, Hersh A, Anderson L, et al. Association of pharmacist prescription of hormonal contraception with unintended pregnancies and Medicaid costs. Obstet Gynecol 2019;133:1238-46.
• Walsh S, Irwin AN, Anderson L, et al. Development of a pharmacist-provided contraceptive service following passage of Oregon House Bill 2879. J Am Pharm Assoc 2019;59(4 suppl):S112-S116.